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The first part of the thesis describes synthesis of 10-( 4-methoxyphenyl)-4,5,9-trithia-deca-
1 ,6-diene (25) as an ajoene mimic and as a mixture of EIZ-geometrical isomers using new 
synthetic methodology. 4,5,9-trithia-dodeca-1,6-diene 9-oxide (43), 4,5,9-trithia-dodeca-,6-
ene 9-oxide (44) and 2,3,7-trithia-deca-4-ene 7-oxide (45) were also successfully 
synthesized as a mixture of EIZ- separable geometrical isomers using the same synthetic 
methodology. The synthesis involved a radical addition and a chemoselective oxidation as 
key steps. Characterisation was carried out by 1H NMR, 13C NMR, IR and HRMS 
spectroscopies. 
The second part of the thesis describes the preparation and characterization of an inclusion 
complex formed between 10-( 4-methoxyphenyl)-4,5,9-trithia-deca-1 ,6-diene 9-oxide (25) as 
a mixture of EIZ-isomers with heptakis (2,3-tri-O-methyl)-13 CD) TRIMEB. Characterisation of 
the complex was achieved using 1H NMR spectroscopy, Powder X-ray diffraction, hot stage 
microscopy and Differential Scanning calorimetry. Single crystal X-ray diffraction revealed 
that the complex is orthorhombic, crystallizing in the space group P212121 with unit cell 
parameters a = 14.7900(2), b = 21.4857(2), c = 27.9036(4) A and Z = 4 complex units per 
cell. The guest molecule adopts a hairpin conformation with the sulfoxide moiety located 
near the cavity 'roof' and the methoxyphenyl and allyl residues directed towards the 
secondary rim of the host molecule. 
The final part describes the biological activity of the synthesized ajoene analogues together 
with that of the inclusion complex regarding their ability to inhibit cell growth of WHC01 
cancer cells using an MTT colourimetric assay. The WHC01 cell-line is an oesophageal 
cancer cell-line of South African origin which was originally established from surgical 
biopsies of primary oesophageal squamous cell carcinomas. All the biological tests were 
conducted at the UCT Medical School. IC50 values were calculated and compared with that 
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Chapter 1 Literature review 
Chapter 1: Literature review 
1.1 Introduction 
This chapter will offer an overview of the literature relevant to this research project. First it will 
include a general overview of garlic together with a history of allicin and ajoene. An overview of 
cancer and its cell-cycle in humans as well as a description of apoptosis will be followed by a 
presentation of ajoene and various aspects of its activity with the emphasis on mechanism and 
cancer. Following this comes the cyclodextrin-inclusion section. 
1.2 Overview of Garlic 
Garlic, Allium sativum L., is a plant belonging to the Uliaceae family that is commonly used in 
cooking worldwide and which has been used as a medicinal agent for many decades. 1 It has 
generated much interest throughout human history as a food and medicine, and is one of the 
most researched medicinal plants. Its folklore and therapeutic benefits date back about five 
thousand years to the Middle and Far East, and probably originated in the advanced civilizations 
of the Indus valley, from where it was imported to China before spreading to Egypt, Greece and 
throughout the Roman Empire into Europe. 2-4 In ancient civilizations, garlic was used as a 
treatment for various ailments including headaches, burns and wounds, colds, worms, stings, 
bites, tumours, heart disease and ulcers. 5 It possesses potent antibacterial, antifungal and 
antiparasitic activity against a range of microorganisms.6,? Mechanistic investigation over the 
last few years suggests that by virtue of its strong antioxidant properties garlic may either 
prevent or decrease the occurrence of major chronic diseases such as cancer, which are mainly 
due to the abundance of free radicals. 8 In particular, it has been demonstrated that garlic 
reduces serum cholesterol and triglyceride levels, inhibits platelet aggregation, stimulates 
immune effector cells and acts on bacteria, viruses and alimentary parasites.6,? Other 
pharmacological activities reported for garlic include hypoglycemic, hypolipidemic, antitumor, 
antioxidant, antiatherogenic, inhibition of platelet aggregation and also vasolidation. Garlic 
extracts have also shown to have immunomodulatory and anti-inflammatory properties. The 
biological activities and health-promoting effects of garlic are attributed to the presence or 
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The earliest chemical studies on garlic were reported in 1844 by the German chemist Theodor 
Wertheim, who studied the steam-distillation of crushed garlic in boiling water, and identified a 
pungent-smelling oil produced in the steam. He then proposed the name allyl from allium for the 
hydrocarbon groups in the oil.12 In 1892, another German chemist, F. W Semmler, carried out a 
steam-distillation on garlic cloves that produced an oil possessing antimicrobial properties. 13,14 
He observed that two grams of oil were produced for every kilogram of garlic. A little over five 
decades later in 1944, Cavallito and Bailey reported the isolation and identification of the 
component responsible for the antibacterial activity of garlic. 15,16 They observed that different 
methods of extraction (Figure 2) gave different compounds, which were identified as diallyl 
disulfide from the ethanol extract, allicin (diallyl thiosulfinate) from the ethanol and water extract 
and alliin from steam distillation. The ethanol and water extract displayed the most potent 
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Garlic Cloves 




Diallyl Disulfide Allicin Alliin 
Figure 2: Major organo-sulfur compounds extracted from garlic cloves employing various extraction methods. 15,16 
The final proof of the chemical structure came in 1947 when it was shown that allicin was 
identical to the compound obtained from selectively oxidizing diallyl disulfide with peracetic acid 







Figure 3: Selective oxidation of diallyl disulfide to allicin. 17 
Hence its structure was assigned as diallyl thiosulfinate or 2-propenyl-2-propenethiosulfinate 
according to IUPAC nomenclature. In accordance with the literature, 'diallyl thiosulfinate' will be 
used in this thesis. 
1.3 Allicin 
1.3.1 Discovery and synthetic aspects of Allicin 
Allicin (diallyl thiosulfinate) is a member of a class of unstable and reactive organosulfur 
compounds known as thiosulfinates and is the most abundant organic compound in freshly-
crushed garlic, as well as the principal biologically-active substance. In 1949, Stoll and Seebeck 
reported the isolation, identification and synthesis of S-(allyl)-L-cysteine sulfoxide as a substrate 
from garlic, which they named alliin. 18.19 Alliin is a remarkable molecule in that it was the first 
natural substance found to display enantiomerism at sulfur, ie one involving two chiral forms due 
to the asymmetry at sulfur. Nature favours the (+)-S-isomer which in itself does not have 
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unusually high amounts in garlic cloves as at least 10% of the total protein content. 19 Allinase 
has 10 cysteine residues, all of them in S-S bridges, and their reduction and removal of the 
pyridoxal coenzyme factor renders the enzyme inactive. Cross-section analysis has indicated 
that the enzyme allinase and the substrate alliin are located in different compartments. This 
organization suggests a potential defense mechanism against microbial pathogens of the soil, in 
that invasion of the cloves by fungi and other soil pathogens destroys the membrane that 
encloses the compartments that contain the enzyme and the substrate, resulting in interaction 
between allin and allinase to produce allicin, which inactivates the invader. The overall equation 
and mechanism of formation of allicin is shown in Scheme 1 involving elimination of allin by the 














.. ~S'S~ + 
Allicin 
Scheme 1: Generation of allicin from allin in a garlic clove. 6 
Pure allicin is poorly miscible in aqueous solution. It has the typical odor of freshly crushed 
garlic,7 and its stability has been investigated in different solvent systems. Although neat allicin 
decomposes rapidly at 3rC, it is more stable in protic methanol than aprotic polar ethyl acetate. 
Approximately 90% of the allicin remained after incubation at 3rC for 5 h in water at pH 1.2 and 
7.5, while only traces of it could be detected after it was incubated in blood for 5 min.21-25 Block 
answered the question of the thermal instability of neat allicin in the 1970's and 1980's by 
reporting that allicin fragments into thioacrolein and 2-propenesulfenic acid.26,27 The presence of 
an allylic hydrogen adjacent to the sulfenyl sulfur is very crucial for this fragmentation, which is 
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The fragmentation products, allylsulfenic acid and thioacrolein themselves undergo further 
reactions. Thioacrolein dimerizes in a hetero Diels-Alder cycloaddition reaction to form 
regioisomeric dithiins.28 
2~S -- Cs~ I s + 
1,3 dithiin 1,2 dithiin 
Scheme 3: Heterodimerization of thioacrolein to form dithiins 
Alternatively, allicin may participate in a pathway initiated by reaction with itself, with the end-
product being the interesting product ajoene as shown in Scheme 4 below. The latter has 
elicited huge interest as an anti-cancer and anti-thrombotic agent over the last twenty years 
since its discovery. 
a 
II 











Scheme 4: Rearrangement of allicin to (E/Z)-ajoene28 
1.4 Ajoene 
1.4.1 Discovery of Ajoene 
R. Apitz-Castro and M. K Jain of the CSIC (Consejo Superior de Investigaciones Cientificas) in 
Venezuela together with Professor Eric Block of Albany University, State of New York in the US 
established the structure of ajoene to be 4, 5, 9-trithiadodeca-1, 6, 11-triene-9-oxide in the early 
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garlic in Spanish. Studies carried out by Block revealed that ajoene exists as a mixture of E- and 




Figure 4: Chemical structures of the isomers of ajoene29 
Ajoene is more stable than allicin, and contains a sulfoxide with a very rarely-seen vinyl disulfide 
functionality.3o The biological activity of ajoene has been extensively investigated in the past 20 
years, and originally the focus was on its anti-thrombotic activity. However, recently it has been 
demonstrated to posses a range of biological activities including antimicrobial, anti-obesity, 
antifungal and anti-cancer activity.31-36 In vivo experiments have shown that ajoene prevents 
platelet loss by inhibition of both the lipoxygenase pathway and tyrosine phosphatase activity in 
human platelets and that it lowers cholesterol biosynthesis through HMG-CoA-reductase 
inhibition.37-39 Ajoene exerts potent inhibitory effects on platelet activation, platelet binding to 
damaged blood vessel walls as well as thrombus formation.40-42 
1.4.2 Anti-cancer activity of ajoene 
Ajoene has been reported to have therapeutic medicinal benefits, such as anti-cancer,35,36 anti-
fungal,29 anti-trypanosomal,34 antithrombotic,43-46 anti-malaria,29 antiviral,44 anti-obesity,33,47 and 
anti-inflammatory.48 Ajoene also lowers triacylglycerol49 and cholesterol,50 blood levels and 
inhibits a number of enzymes such as lipoxygenase,51.52 cyclooxygenase (COX_2),53 
prostaglandin synthase,54 inducible nitric oxide synthase, 54 human gastric Iipase,5o glutathione 
reductase and trypanothione reductase. 55 In this section we will focus on the anti-cancer activity 
of ajoene of relevance to this thesis and review experiments conducted to unravel this activity. 
First a review of key aspects of cancer is given. 
1.4.3 Cancer 
Cancer is a disease that occurs as a result of the suppression of all apoptosis (programmed 
cell-death) and/or increased cell-proliferation, and proteins that sense cellular damage or growth 
signals arrest the cell-cycle so that the damage can be repaired or, if that is impossible, 
apoptosis is induced. Malfunction of this system leads to cancer by allowing cells to proliferate 
when they should either be repaired or die. Most human carcinogenesis has been shown to 
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mutations of the retinoblastoma gene result in a loss of functioning of the retinoblastoma 
protein, leading to a wide range of human cancers, including osteosarcomas, small-ceil lung 
cancer lung cancer and breast cancer, The cell-cycle is contro lled by proteins called cyclins 
and their catalytic partners, "" The miscoding mutations of a cyclin results in a loss of affinity fe.-
its catalyt'lc protein. This can take place due to epigenetic inactivation by methylat'lon in a variety 
of tumours, Other types of cancers can be due to cI1romosal rearrangement. In most human 
cancer ceHs, the cydins that have been observed to mutate are CDK4/6 cyclins, For examp~ . It 
has been observed that a mlscoding mutatioo of CDK4/6 resulted in a loss of P16 binding. By 
comparison, alterations at CDK2 Or cyclin A are rare and mutations at E2F family members 
have not been identified. The alterat ion of cel l-cycle are p<Jssibie targets for therapeutic 
interventions. There have been attempts to exploit this by treating cancer patients with inhibite.-s 
that block CDK activity, and indirubicin. fiavopiridot and UCN-Ol were the first CDK inhibite.-s 
tested in clinocal trials in which benefits have been noted in some patients,"" 
1.4.4 Cell-Cycle in Human Disease 
To ensure a proper progression through the cell-cycle, cells have developed a series of 
checkpoints that prevent them from entering into a new phase until they have successfully 
completed the previous one. As previously mentioned, this is controHed by cyclins and theIr 
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Growth factor signals stimulate the synthesis of D-type cyclins, which then form active complex 
with CDK4 and CDK6 active complexes in the early G1 phase. The primary substrate of CDK4/6 
is the retinoblastoma protein (pRb), which in its active, hypo phosphorylated form inhibits cell-
cycle progression by binding and repressing the activity of the transcription factor E2F.56 The 
transcription of several genes takes place in the G1-to-S transition by hyperphosphorylating the 
pRb which causes it to disassociate from E2F, and these genes include E-type cyclins. The 
activation of the cyclin E/CDK2 complex drives progression from the G1 to S phase. The 
appropriate completion of deoxyribonucleic acid (DNA) synthesis in its S phase requires the 
activity of A-type cyclins together with CDK2. The B/CDK1 complex regulates entry to mitosis, 
whereas proteolytic degradation of B-type cyclins regulates the exit from mitosis. Other CDKI 
cyclin complexes are regulated as follows: (i) inhibitory or activating phosphorylation; (ii) 
inhibition by specific CDK inhibitors (CKls) such as p16, p21IWAF1, p27/KIP1 or (iii) by targeted 
degradation, mediated for example by the SCF (Skp1 - Cullin - F-boxprotein) ubiquitin ligase. It 
has been observed that in tumour or cancer cells the cyclin dependent kinase inhibitory proteins 
are either absent or mediated.56 
1.4.5 Apoptosis 
Apoptosis is an active energy-dependent genetically programmed process that occurs widely 
during mammalian development. It offers a practical way of getting rid of old, damaged or 
dangerous cells, and is mediated by 2 major pathways known as mitochondrial and death-
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Two pathways are irltimately connected. arid sometimes the death receptor-mediated apoptotic 
stimulus is am~ilied by the mitochoodrialloop. The death receptor is an extrinsic pathway and 
is triggered by extracellular cUeS such as grolVlh factor wilhdrawal, matrix detachment and 
cytokine-mediated killing. It begins when a death-ligand such as tumor necrosis factor (TNF), 
Fas-ligand (FasL) or tumor necrosis factor-related apoptosis-inducing ligand (TRAIL or Apo2L) 
interacts with its corresponding receplor (TNF receptor, Fas receptor or KILLER/DR4 and DRS 
respectively) leading 10 the activation of a caspase cascade pathway, which results In lhe 
cleavage 01 proteins lhal are essential to cel l viability." The mitochondrial cascade is lhe 
intrinsic palhway and mighl be lriggered by intracellular cUeS such as DNA damage or osmotic 
stress. The first genetic component of the human ce ll-death pathway to be iderltified was the B-
eel/ CLUlymphoma 2 (Bcl2) gene. Th is pathway is mediated by BcI-2 family proteins, which 
consist of 20 members that have been recognised and described in humans" The relative 
ratios 01 anti- and pro-apoptotic Bd-2 family proteins dictate the ultimate sensitivity or resistance 
of cel ls to various apoplotic stimuli. including grovvth factor depletion, hypoxia, radiation and 
antlcarlcer drugs. In response lO apoptotic signals. proapoptotic BcI-2 family proteins such as 
Bax transo cate and alter the permeability of the mitochondria l membrane, leading to 
cytochrome C release and activalion of the caspase cascade. Anti-apoptotic BeI -2 family 
members such as BcI -2 and Bel -xL counter these effects. "" It was then concluded Ihat the 
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1.4.6 In vivo and in vitro studies on ajoene 
Early reports on the anti-cancer activity of garlic oils in skin tumourgenesis were carried out by 
Belman in the early 1980'S.9 A detailed study of ajoene inducing apoptosis in a human 
promyeolocytic leukemia cell-line HL-60 was reported by Dirsch and coworkers at the Institute 
of Pharmacology, Toxicology, and Pharmacy in Munich Germany in 1998.54 The aim of their 
study was to examine how ajoene is able to induce apoptosis in a human promyeolocytic 
leukemia cell-line HL-60.54 This cell-line was chosen since it provides a valid model system for 
the testing of antileukemic or general antitumoral compounds (Suh et al. 1995). A human 
Promyeolocytic HL-60 cell-line was cultured in a humidified atmosphere (37°C with 5% CO2) in 
order to generate conditions similar to those in the human body. 54 The cell viability of cultured 
cells was confirmed by an MTT assay involving reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) to formazan. MTT is a yellow tetrazolium salt which turns to 
purple in the formation of formazan by metabolic active cells. This cellular mechanism involves 
the pyridine nucleofactors NADH and NADPH as shown in Scheme 5 below. Destruction of cells 
shuts off the reduction with retention of the yellow colour. Thus a chemical interference of cells 
can be followed colourimetrically. 
NADH/NADPH .. 
MTT (yellow salt) Formazan (purple solution) 
Scheme 5: Reduction of MTI to formazan by NADPH/NADH in active cells 
The control of this study was human peripheral mononuclear blood cells of healthy volunteers. 
Ell ajoene was disolved in less than 0.1% dimethyl sulfoxide and then added to cells in various 
concentrations (1-80 fJM) for different time intervals. Apoptosis was examined by cell 
morphology, flow cytometry and DNA gel-electrophoresis. The results obtained from these 
experiments revealed that ajoene induces morphological changes that are characteristic of 
apoptosis in HL-60 cells. Flow cytometric analysis showed that ajoene-treated cancer cells had 
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consistency of apoptotic cells as shown in Figure 7, This means that the DNA of ajoelle-treated 
cells fragments 
fj~ " .. ), ' low 'JI'''-" ,", '"~1'" ,f ' P' r"~ ' A C ~ I " ," If '"''',," <.C''''') ,"" Q" , ~j y I,d • .c,lI«) on~I'" or urhot td c ~ ~ 
B Forw.d ",d ~d • .cJtl«.Miy,. , of ~ o ..,.-t,,,t,d 110 ~1 , 10 " ) c ~ I"'" 
Condensation of chromatin and the appearance of apoptotic bodies were also observed. The 
DNA fluorescence histograms of P,-stained cells confirmed DNA fragmention in ajoene-treated 
cet ls This was shown by the low DNA stainabil ity of the ajoene-treated cancer cells which 
resulted in a distinct quantifiable region below the G, peak, whereas in untreated cells the G, 
peak predominates as shown in Figure 8C 
Fi'l'" e 8: H,slo 9 rams of Pl -Fluo 'escen ce C Unt 'eated HL·50 cell, D Ap p "aranc " of cells with 
sub d 'P 10 ,d 0 NA co ntenl afler Ire. lmenl I'oith aJo ene" 
In histogram 80 there was appearance of a subdipklid DNA content (Ap means apoptotic) after 
treatment with ajoene which indicates that apoptosls was ta~ing place Agarose gel 
electropil<lresis also confirmed that there was a typical DNA fragmentation in ajoene-treated 
cancer cells (1-40 jJm) as shown in Figure 9A'~ The DNA of the control was intact, whereas that 
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Quantification of dose dependency was established by monltorong Ihe amounl of nuclei with 
sutxliploid DNA content by uSing fiow cytomelry. II was found that there was a time-dependent 
increase of subdiploid DNA. which is shown in Figures 9B and ge. Ajoene in concentrations 
higher Ihan 5 !-1m incubated for 20 h increased the percentage of apoptotic cells up to 60%. 
They concluded from this study that ajoene does induce apoptosis on a human leukemia cell-
line HL-60 
Although Dirsch had proved that ajoene induces apoptosis on human leukemia cell - lines, the 
mechanism under1ying apoptosis Induction stili needed to be elucidated . The second 
investigation carried out by Dirsch and coworkers and published in 2002 focused on 
understanding the mechanism underlying apoptosis induction. '"" In itiatly they investigated if the 
ajoene apoptotic activity was due to oxidalive stress mediated by the generation of reactive 
oxygen species. such as peroxide. Previous slud ies had shown that an important mechanism by 
which compounds induce apoptosis is through generation of reactive oxygen species (Buttke 
and Sandstrom, 1(94). Therefore, the production of reactive oxygen species was measured by 
flow cytometry as shown prev iously by Vollmar el a/ in 1997 Intracellular peroxide production 
was proved by measunng oXidalion of Ihe dye DihyeJrorhodamine 123 (DHR- (23) in HL-60 cells 
DHR 123 is a non-fiuorescent mitochondrial dye that is oxid ised to the green fluorescent 












Rhodamine 123 (green fl..orescent) 
Sctwrn. 6 O>idati on of Di IR·123 \0 Rhoo,.m"" b~ pernroe 
The resu~s obulined revealed a time-depend&nl Pfodudion of perOXIdes In apoene·treated coils. 
Tho, p&roKide prodUGtion was decreased by 50% when an antJoKldanl N-aoety\cysleine (NAG) 
was added. Figu.-e I DS. Previous studies carried out by Gnmm 8/ (J/ 1996 toad shown that the 
nuclear facto< protein NF-ocfI that IS known 10 Induce o';da~ve stress IS also IMolved In 
signall ing of the apcptolic proUlSS. Dirscn and coworkers Ihus Investigated the effect of ajoen(! 
In tM act ivatIOn of transcriptIOn factor NF. ~ B . An EMSA (!xperimenl (whi cl1 is a technIque used 
to characterize prot(!in:DNAIRNA Interact ions) w as conducted as previous ly e~ pla l ned in Boose 
et III 1996 and they revealed thaI ajoene (10 ~M , 3 h) was able to act ivate the nuclear 























FkJ, re 10: A DHR t ,2,3-lo~ded HL-60 ,. 11 . B P"ro" de '",e '. in thre e different "rw I ro nmen(~ 
Similarly, ajoone administered in peripheral mononuclear blood cells (PBMCj of a patient 
suffering from a chronic myeloid blast crisis with the percentage of myeloblasts (a precursor of 
leukocytes that normally occurs only in bone marrow) at 70%. confirmed that aioene induces 
apoptosis even in chronic leukemia cell s. In healthy cells. ajoene did not induce apoptosis in 
qUIescent and proliferahng PBMC. and it was found that there was no morphIJlogical or DNA 
fragmentation in these cells _ These studies have thus demonslrated that ajoene mdu:;;es 
apoptosis in a human acute myeloid leukemia cell-line HL-60 as well as in peripheral blood 
mononuclear cells (PBMCj isolated from a patient with a chronic myelogeneous leukemia 
undergoing a myelOid blast crisis but. importantly, not in healthy ce lls In additi<ln, aJoone-
induced apoptosis in these cel ls is accompanied by the generation of reactive oxygen species 
and activation of nuclear factor KB 
Most of the atte!1tioo on ajoene has been given to the natural product as a mixture of Z- and E-
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EIZ ajoene (50, 100, and 250 IJg respectively) before TPA was applied. Experiments were then 
monitored over 18 weeks, calculating the percentage of mice bearing tumours and the mean 
number of tumours per mouse calculated as shown in Table 1 below. 
Table 1: Inhibition percentage in different mouse groups59 
Group Treatment Mean no of tumors Inhibition percentage 
1 TPA (positive control) 12.2±1.7 -
2 TPA + 50 j.Jg ajoene 4.0±2.7 67.2 
3 TPA + 100 j.Jg ajoene 1.2±1.2 90.2 
4 TPA + 250 j.Jg ajoene 0.6±0.4 95.1 
It was found that all 5 mice in group 1 bore tumours with a mean of more than 10 tumours per 
mouse. The results showed that as the percentage of ajoene used increased, the number of 
tumours decreased. These findings shows that ajoene offers strong protection against TPA-
promoted carcinogenesis on the mouse skin, which proves an in vivo anti-cancer activity for 
ajoene. 
Min Li of France and co-workers carried out both in vivo and in vitro studies on the antitumor 
activity of Z-ajoene in 2002.60 The first experiment was focused on the effect of Z-ajoene on cell 
proliferation and cell distribution. Z-ajoene was extracted from a garlic extract using 
cyclohexane and purified to more than a 98% purity.60 Seven human cell-lines, namely, breast 
cancer (MCF-7), nasopharyngeal carcinoma (KB), heptocellular carcinoma (Bel 7402), gastric 
carcinoma (BGC 823), colon carcinoma (HCT), Hela cells (Hela) and promyeololeukemia cells 
(HL60) were grown in a humidified environment (3r C; 5% CO2). The control was a marsupial 
kidney cell-line (PTK2). Cells were then exposed to an increasing ajoene concentration (1-80 
IJM) for 48 h before addition of MTT. Plates were read at 570 nm using a Bio-Rad 3500 
microplate reader. The concentrations of a compound required to reduce the absorbancy to 
50% versus the control cells (lC50), were determined from replicates using linear interpolation 
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Table 2: ICso on different human cancer cell lines treated for 48 h
60 









It was observed that Z-ajoene was the most biologically active in HL60 and the KB cell-lines as 
indicated by a low IGso . These two cell-lines were then chosen with the control (PTK2) cell-line 
to determine the cytotoxic activity of Z-ajoene. A dose-dependent cytotoxic activity in HL60 and 
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Figure 12: Effect of Z-ajoene on cytotoxity. Three cell lines (KB), (PtK2) and (HL60) resp ectiv ely60 
The control (PtK2) cell-line was resistant to the cytotoxic activity of ajoene while the KB and 
HL60 cell-lines showed the cytotoxic effect of ajoene. When the cellular DNA of the HL60 cells 
was analysed by flow cytometry, it was found that Z-ajoene had induced the accumulation of the 
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study of Yoshida found that the Z-isomer exhibits an antimicrobial activity at least twofold higher 
that of the E-isomer.32 Also, the Z-isomer has been previously found to inhibit cell growth and to 
induce apoptosis with unknown activity on tumour cells. Nishikawa and co-workers then did an 
in vivo investigation of the antitumor effects of Z-ajoene in a two-stage carcinogenesis test on a 
mouse skin.59 The reason for their study was that they had observed the antimutagenic effects 
of ajoene against benzo[a]pyrene with Salmonella typhimurium. Benzo[a]pyrene is a potent 










Figure 11: Formation of DNA adducts by pyrene. 
Z-Ajoene of more than 98% purity was prepared by the method of Block.26 Male mice of 7 
weeks old, weighing 32-35 g were housed in plastic cages at 23-25 °C individually at a 50% 
humidity with a 12-h light-dark cycle. Each mouse was provided with water and standard 
laboratory feeding during the course of the experiment. They were then shaved and applied with 
7,12,-Dimethylbenz[a]anthracene (DMBA) (50 I-Ig, 190 nmol) as the carcinogenic initiator in 
acetone. The structure of DMBA resembles that of Benzo[a]pyrene as a polycyclic aromatic, in 
Figure 11. It thus also intercalates into DNA in the same way as Benzo[a]pyrene. After DMBA 
was added, a week was allowed to promote tumour growth by adding 12-0-
tetradecanoylphorbol-13-acetate (TPA which propagates tumour growth) (1 I-Ig, 1.6 nmol) in 
acetone in the same place. TPA is a phorbol ester and active component of croton oil. It mimics 
the second messenger diacylglycerol to activate protein kinase C (PKC) and alter cell signalling 
pathways (Reviewed in Gottlicher 1999). The mice were then divided into 4 groups of 5 mice 
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In the control. there is a high content of Gt cells whereas e~posure to 5-80 ~M Z-a]oene 
Iflo;teases the number of cells blocked In GiM pha~ The II1cfease 01 G,IM phase celis can be 
e ~plalned by the mcrease of dead cella. which will be explained in the cell-<::ycte section. Since 
compounds with anUtumour achity have been $hown 10 interact wilh microtubule or tubulin in 
Ofl;Jer to inhibit cell pl"oIifera~on and bIodl mitosis ... • u lhen decided to determine the effect of Z-
ajo_ on microtubule cytoskeleton. The ~IK2 ce il -line was chosoo since they are e~l erlSlve 
With th inly spreading microtubules Cells were grown In a humidified environment and then 
treated with 1-20 ~M of Z-aj<;lene for 8n, The ce ll s were then permeabili zad at roOO1 temperature 
Witt'! a 0 050/0 Trilon solution. Triton (Octyl phenol ethoxylate (C,.H".,o,), ~ a non~on lc detergent 
thai removes all cytoplasmiC membrane contamination but does not change the cell 
morphology After washing WIth t"lon. CellS were incubated wilh a mouse monoelonal Bnllbod)' 
O-Iuboiin. A secondary an~body FITe conlugate ) which IS essential for delectlng or anal'lling 
target protems bound by the prim:.y antibody was also used 111 ItoIS EUSA study. ChromO$Omes 
were Slalned WItt'! OAPI (0 2 ~glmIJ . The control was InJecled with the anhbodlel; only. lind not 
treated WIth ajoene. The intensity of the ftuOfescent {greefll nelwor1< was quantified by lhe 
FLUOSTar Galaxy The re sulls shOl'o'ed a dose-dependent reducUon of mil;lotuOUles in Z-ajoene 
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Fig"," 13: DemonstratIOn 01 ml ( rotubul e d Isassemb If" 
The microtubule cyloske""ton of the control (Figure 13 AJ appeared to be intact. whereos that of 
Z-ajoene treated cells (Figures 13 B, C and DJ was dose-dependently reduced. This agrees with 
Nishikawa's findings on the in vivo activity of ajoene -',o 
In vitro studies were also conducted on Kunming mice 4-6 weeks old Kunrning mice are the 
most widely used outbred colony in Chino. Two transplanted tumors, hepatocarc;noma 22 (H22) 
and sarcoma 180 (S180) were implanted In each mooel tumour cells were induced in 30 mice 
by subcutaneous injection of 0.2 ml Phosphate buffer solution (pH 7.4) containing 5 x 1ef' tumor 
cells. on the right fiank at day one. The animals were divided into three groups (10 mice) two for 
testing and one as a control. On day two, the experimental group injected with hepatocarcinoma 
22 received 2 and 4 mglkg of the Z-ajoene every day intraperitoneously, The experimental 
group injected with SarCOma 180 cells received 4 and 8 mglkg aloene under the same 
conditions, Twelve days later the mice were killed , tumours were weighed and the inhibition rote 
was calculated in comparison with the control The results showed that inhibition rotes for S180 
Implanted mice were 10 and 32% while for the H22 transplanted miCe, the inhibition rate was 32 



















Fi<J"'~ lJ: Effect of Z-aj oen" in transp lanted tumor gTOwthetl 
Literature review 
In condusion, Li and co-workers successively demonstrated the antitumor activity of Z-ajoene 
both in vivo (on microtubulesj and in vtlro (on mice) 
Aje>el'l€ has ooen shown to induce apoptosis in both in vivo and in vitro in the above dis.cussed 
studies However, the mechanism of action of ajoene was not known prior to 2002. \\/hen Oirsch 
and co-workers published the first inSight into the molecular events leading to ajoel'l€-triggered 
apoptosis. The first study was to identify the molecular pathway leading to ajoene-triggered 
apoptosis in leukemia cells. Two major pathways mediating drug-induced apoptosis have been 
characterized"; One inv~ves the triggering of celt-surface death receptors and the other targets 
the mitochondria without the involvement of a receptor/ligand system. The cell-surface mediated 
pathway occurs when a death tigand interacts WIth the receptor leading to the activation of a 
caspase cascade. which involves proteins that are essential to cell viability and is further 
explained in lhe apoptosis section. The receptor that is involved in apoptosis evoked by 
chemotherap€utic drugs is the COgS (APO-lIFas) receptor system ·J·~' Activation 01 the COgS 
receptor by a death COgS ligand leads to recruitment of FAOO [Fas-associated protein with 
death domain] and procaspase 8 forming a death-induced signalling complex'" Dep€nding on 
the cell typ€, large amounts 01 procaspase leads to the activation of a caspase cascade 
indep€ndent of the mitochondria (typ€ I cells). while small amounts leads to a pathway amplified 
by the mitochondria-controll ed caspase cascade (type II cells) C," The second pathway occurs in 
the absence of a CO-95 receptor ligand system ,"' This event is characterised by a mitochondrial 
membrane p€rmeabilisation which causes loss of the mitochondrial transmembrane potential 
with the release of cychrome C into the cytosol. This is because the proteins (Bd-2) that serves 
as the mitochondrial gateway have lost their activ ity/function, The l irst experiment was done to 
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hUman acute myeloid leukemia cells line HL-60 was cultured in a humidified environment, and 
cells were stimulated with ajoene (20 ~M) or Etoposide (10 ~g!ml) for different periods of time 
(0-22 h), Etoposide is a chemotherapeutic drug that is given as a treatment to some types of 
cancer, Cells were then collected by centrifugation washed with ice- cold PBS and lysed in 
5mM MgCI,; Iysates were then stored at _70°C until further analysls_ The results showed a time-
dependency activity of ajoene that was more detecta~e after 5 h as shown in Figure 15, 
'" eo ---
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Fiq",e 15, Tim e- d ep end ent ind "ctio n of "PO pto si s In HL-60 cot ls by "iu ono PJ ~M)" 
The activity of caspase was investigated by cleavage of PARP (a nuclear protein involved in 
DNA repairing, and cleaved by caspase) using western blotting , Results in Figure 16 show a 
time-dependent activation of Gaspase-3-like protease. 









Figure 16: Tlme- d ep en d ent (Iea~ ag e of PAR ~l 
Treatment of HL-60 celts with ajoene (1-24 h) resulted in proteolytic cleavage of caspase-3 to 
the active p17 subunit as shown in Figure 17A. Caspase 8 is naturally expressed as an inactive 
precursor in two isoforms, caspase 8a and caspase ab, which appear as two protein bandS of 
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Recruitment of both caspase 3 and caspase 8 proves that Ajoene induces 8poptosis through 
the caspase cascade pathway. w-hat was not known was whether this was mitochondMal-
mediated or CO-9S receptor mediated Experimellts were conducted to allalyse if ajoene-
induced apoptosis occurs independelltly of the CO-gS receptor system . Cells were incubated at 
4 ' C for 30 min with mouse anti-COgS-body or the isotype control mouse IgG· CO-9S antibody 
fluoresces red while the IgG, antilxxiy fluoresces green Cells were then analysed by flow 
immunofluorescent flow cytometry_ It was observed that ajoene-induced apoptosis was 
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Figur" 18: "'j oenes .po ~trnic eff "ct" 
Even on additioll of the caspase-8 inhibitor ZITO-FMK, this event could not be blocked as 
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Figure 19: The casp ~ "" Inhibltorz lETD-lmk unable to abcoQate ajoene- i nduced DNA 1 rag mentatlo n" 
This study established that ajoene induced apoptosis in a HL60 cell i ne is not CD95 receptor-
mediated. The last experiment was to investigate if this activity is mitoc:hondria mediated This 
was done by inveshgating the selective ability of the mitochondria membrane, HL-50 leukemia 
cells were treated with ajoene (20 IJM) for various time periods (0-24 h) and stained with 
~uoroc:hrome 5, 5' 6-6' tetrachloro-l, 1', 3, 3'-tetraethylbenzamidozol carbocyanine iodkle (JC-l: 
1 25 (JM) JC-l was used for fluorescence purposes as it fluoresces red. After incubation at 37 
' C for 20 min in the dark the membrane potential was measured by 1101'1 cytometry , The 
mltoc:hondrial membrane permeabilization (MMP) affecting the outer and inner membrane is the 
key event in mitochondria-controlled cell death,"' The outer membrane permeabilization involves 
the release 01 cytochrome C which is confined to lhe intermembrane space, The inner 
membrane permeabilizalion is then indicated by dissipation of an electrochemical gradient 
(ll ... ,, ) created by the proteins of the respiratory chain located on the inner mitochoc:hondrial 
membrane, A time-dependent retease of cytoc:hrome C inlo the cytosol upon addition 01 ajoene 
(20 IJM) was observed as shown in Figure 20, A significantly increased level of cytochrome C in 
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ritlill e 20: A decrease in mitorhondri" ryto rhrome C, foll owed by a n increase of rytoctvome C in 
the cytoso~l 
The selectivily of ti"le inner membrane was assessed indirectty by delermining a reduction in 
(Ll."I',,). This was achieved by incubating cells with fluorochrome JC-l , which forms aggregates 
(red) or monomers (green) depending on (fllli.,, )· Untreated cells loaded with JC-1 displayed red 
fluorescmg mitOchondria referring to intact filii" Cells treated with ajoene exhibited green 
fluoresang cells corresponding to JC-1 monomer formation and loss of filii" as shown in Figure 
21. 
Untreated cells Aioene 20 uM 
F iuure 21: Re d fluorescing Unl,eated celiS and (Tee n fluore sci ng ajoe ne treated ce llsl1 
This shows that the inner membrane was also no longer selective. These studies proved that 
both inner and outer mitochondria membrane were no longer selective in HL60 ajoene-treated 
cells. Proteins that guard the mitochondrid gate making it selective belong to the Bd-2 family.'" 
Overexpress,on of these proteins can block cytochrome C release and thereby the activation of 
easpases downstream of mitochondria. '" Dirsch and coworkers observed that ajoene-treated 
cells showed a low redistribution of cytochrome C and therefore they then investigated whether 
this was due to the activation occurring downstream of the mitochondria. Two types of cell 
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second one was the HL-60 one that overexpressed Bcl-xL proteinS. In HL-60IBd-xL cells, 
aJDene's apoptotic activity was significantly reduced as shown in Figure 22 below. 
< •• Hl·60'neo Hl·60J" " '· . L ~ 
' \ 
I • 0 ~ .. .:: !:: ' w .,"" c , • 0 I K " '" - -" , Q J ~ 1 " . , 11 . 1 , .1 
Tom<: l ~ ' 
FlUlKe 22: Re d flu n esc inQ u nl reated cell s il nd Qre en fluo rescing aioe ne Ite.ted , ell s'" 
The cells overexpressed with Bd-xL did acti~ate caspase-3 and caspase 8 bul the rate was 
sIgnificantly lower. In normal leukemia cells it took 3 h to activate caspase 3 to its active subunit 
p17, while in cells overexpressing BcI-xLproteins it took 24 h as shown in Figure 22 
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FIgtK e 23: showi nQ the rate of activation of casp ase 3 and caSll ase in norm al leukem i~ 
cells and leukemia cell s o¥erexp re ssed with Bel-xL" 
Caspase 8 was also activated to Its p411p43 active intermediates. From these experiments they 
concilKied that ajoene-treated leukemia cells undergo a time-depenendent reduction in the anti-
apoptotic Bd-2 proteins that promote the release of cytochrome C and the activation of caspase 
3. The results provided compelling evidence that ajoene-induced apoptosis in leukemia cells 
proceeds via a mitochondria-dependent caspase cascade pathway rather than triggering the 
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1. 5 Detailed Mechanism of action of Ajoene in human Glutathione Reductase 
Apene contains a disulphide functional group, which is likely to be involved in its biological 
activlty_ Ajoene aiM contains a sulphoxide and a vinyl group that is conjugated to one of the 
sUlfur atoms of the disulphide rendering it more reactive . Disulphides are considered to be thiol 
oxidizing agents, as they are able to thiolate cyste'lne residues on prote'lns to form mixed 
disulphides, thereby affecting protein or enzyme activity which leads to cell-death As previously 
mentioned, ajoene has been shown to inhibit a number of thiol-containing enzymes such as 
gastric lipase, glutathione reductase and trypanothione but mechanistic studies have been rare 
One exception involves a study of the mechanism of ajoene in inhibiting glutathione reductase. 
Glutathione reductase (GR) is the enzyme used by human cells to combat oxidat'lve stress, and 
is a member of the family of disulphide reductases This fam ily of proteins contain a FAD-redox 
enzyme that interacts with disulphide substrates. The function of glutathione reductase is to 
keep the cellu lar concentration of the reduced form 01 glutathione (GSH) high and that of its 
OXid ized form (GSSG) low for the body's biological functioning The glutathione reductase 
enzyme (E) uses NADPH as a source of its reduction equivalents as 'In the reaction below.oo 
H' + NADPH + E ----> NADP' + EH, 
EH, + GSSG ----> 2GSH + E 
As shown in the reaction above, GR occurs in two stable forms, E (oxidized) and EH, (reduced) 
The first part in the reaction above is the reduction of the enzyme to its reduced form EH" In the 
oxid ized form, the enzyme consists of two subunits which are related to each other by a 2-fold 
axis and covalently bonded by a single disulphide bond as shown in the Figure 24 below. 
F Igme 24: Structure of the ei merlc OOZ)m" Ql l1athlone re d ", tas e as 
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The enz:yme is divided into four domains, of which the first two domains resembte each other 
and these birxl FAD and NADPH respectively. The N terminal is in close proximity 10 the FAD 
wllhout any defined structure in the crystal, whereas the central and interface domain fdlow on 
the C-terminal side, The catalytic centre is therefore made up of five different domains, four 
domains from one subunit arxl the interface domain of the other subunit. The arm consists of 
Cys 2 that coutd possibly reach Cy.> 58 of the redoxactive disulfide bridge, The catatytic centre 
can be divided Into two parts, the one that birxls NADPH arxl the other bind ing GSSG, These 
two parts are separated by a flavin and the redoxactive Cy.>-58:Cy.>-63 d lsutphide bridge as 
shown in Figure 25 below 
Flgll,e 25: The catatytlc ce ntre of Qlutathione red Ll c t~W" 
The two dinucteolides FAD and NADPH bind in elongated conformation to the protein, The 
nicotinamide part of the NADPH is in close contact with the flavin part of FAD, white the 
adenosine moieties of NADPH and FAD are far apart from each other. In the NADPH birxling 
pocket. there is Tyr-lg7 which covers the nicotinamide birxling pocket in the absence of NADPH 
thereby shielding the flavin against the solvent. When NADPH binds to the protein the phenol 
(Tyr 197) moves away from the birxling pocket altowing the nicotinamide to reach the flavin, 
Between the fiavln and GSSG substrate there is a Cy.>-58:Cys-63 disulphide bridge, This 
disutphide bridge contacts the flavin ring near to its C" atoms, On binding of GSSG, Tyr 114 
moves by about 0.1 nm, tis phenol ring then fits between the glycine moieties and glutathiones I 
and II with the hydroxy1 group contacting the disulphide bridge of GSSG, In the reduced form of 
the enzyme the disulphide bridge Cys-58:Cy.>-63 opens up and the sulphur of Cys58 becomes 
reduced, The four states of the catalytic reaction cycle of glutathione reductase are summarised 

















Sch.",.7: Fa", states of the cat. lytic teacti on Ojcl. of yul olh " n' r. Juc la, " SI. te 1 IS the o.iJmd en,yme E 
State21sthe co"'p l • • bel"", . n NADP ' . nJ I .. ",doc. J emym. EH, State3 os the reJ uced .")'Ill< 
EH" , , l .b l< ,. ,oliun i,I . ,meJ i.,e St. t. ! i, a comb.,a:io" of the three C.ta/¥tlC sle,,'" 
It is a big advantage when GSSG is present in high levels and GSH in lower levels in cancer 
cells as this decreases cell division. A crystallographic study that confirms an increase in the 
oxidase activity of glutathione reductase upon addition of ajoene was conducted by Helge 
Gallwltz. Glutathione reductase was incubated with E-ajoene in the presence of NADPH at 
37"C The results showed a 50% inhibition within 15 min. No inhibit ion of GR was observed in 
the absel1Ce of NADPH, which indicated the involvement of NADPH in the active site of the 
enzyme. The activity of the enzyme was not regained upon addition of the substrate 
(glutathione) but 70'10 of its activity could be regained by addition of dithiotreitol, This confirms 
that aJOene is a competitive inhibitor of glutathione reductas e, It was observed that ajoene-
modified GR showed a marked increase in oxidase activity, Substrate-independent oxidation of 
NADPH Increases by a factor of about 5 in the ajoene~nactivated enzyme and the rate of 
cytochrome C reduction is 10-fold higher when compared to the native enzyme. Modification of 
Cys53 is expected to shift electron density towards Ihe flavin flng and Ihus to prcrnote the 
reduction of oxygen at the isoalloxazine ring . This was confirmed by a decrease and a slight 
hypsochromic shift of y,,~,,~ of flavin spectrum and a concomitant absorbance increase. This is 
due to the charge-transfer complex formed between Cys63 and the flavin in the reduced 
enzyme species and is the strong evidence for Cys 58 being the altered protein residue as 
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showed the mechanism by which ajoene inhibits glutathione reductase which involves covalent 
binding to Cys58 to form the modified protein CH,=CH-CH,-SO-CH,-CH=CH-S-Cys58 







Figur~ 26 Ajoe"" covalectl\' """,ds to !he Cy~~ re",doo of Q<Jtat '" oos reductase " 
Figure 26 show the protein crystal structure co-ordinates of the ajoene-modified Cys58 and 
Cys63 In their main conformation The inhibitor fragment (bold lines) is covalently bound to Cys 
58 via a dlsulphide bridge, This type of in hibitor is called a 'turncoat inhibitor' or 'subversive 
substrate' as it has a strong impact on the redox status of the cell It lowers the GSH/GSSG by 
wasting NADPH to proouce unharmful oxygen species in cancer cells, The reaction below 











Chapter 2 Review of synthetic aspects of ajoene 
Chapter 2: Review of synthetic aspects of ajoene 
At the beginning of this research, the only published synthesis of ajoene was Block's 
biomimetic thermal rearrangement of allicin in aqueous acetone.28 This chapter will present 
and discuss Block's method in detail, its advantages and disadvantages, potential synthetic 
strategies for the synthesis of ajoene derivatives and finally the main objectives of this 
project. 
2.1 Block's Biomimetic Synthesis 
Block's method is based on the biomimetic rearrangement of allicin as it occurs in nature. In 
the laboratory, this is achieved by heating allicin in aqueous acetone. Allicin 1, obtained by 
peracetic acid mono-oxidation of diallyl disulfide, self-condenses to an intermediate 3 that 
undergoes a Cope-type elimination to S-allyl vinylthionium ion 4. This re-adds 2-































Block reported that flash chromatography of the concentrate of the crude product gave 17% 
of a mixture of EIZ-isomers in a 4:1 molar ratio. 28 The readily available ajoene 5 allowed an 
in vivo study of antithrombotic activity on rabbits to be carried out. Rabbits were each fed 20 
mg/kg of (EIZ-ajoene) and the results showed a 100% inhibition of collagen-induced platelet 
aggregation for a period of 24 h after feeding. These findings prompted scientists to explore 
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2.2 Disadvantages of Block's synthesis 
The percentage yield of ajoene using Block's methods is very low (17% = 1.6 g product from 
5 kg of garlic bulbs) with the E-isomer dominating the Z-isomer in a 4:1 ratio. 28 A low 
percentage yield of the Z-isomer is a disadvantage in Block's method, since Yoshida's 
studies have demonstrated that the Z-isomer exhibits at least a two-fold higher antimicrobial 
activity than its E-isomer. 32 A new synthetic strategy that would increase the percentage 
yield of ajoene with the Z-isomer dominating was thus in demand. The literature indicates 
that the disulfide group is a key motif in chemistry, biology, pharmaceutical and material 
science. 75-81 Thus, it would be of great advantage if a new synthetic approach could be 
developed that retains the pharmacophore (vinyl disulfide group) and the sulfoxide group 
while varying the allyl end groups for generating analogues for biological evaluation. 
Regarding the scope of Block's synthesis, the sulfenyl allyl group is essential for the 
rearrangement. Thus, only the group on the sulfoxide side can be varied. This places a 
serious limitation on Block's method for preparing analogues as the latter can only be 
obtained varying the one group (R1) as shown in Figure 27. 
Ha s to be allyl 
o J 
2 R{",·g,"-S~ ---------
Figure 27: Rearrangement of rrodified allicin 
2.3 Potential Synthetic Strategies for Ajoene Synthesis 
2.3.1 Introduction 
Various synthetic disconnections may be considered for possibly accessing the ajoene 





Figure 28: General structure of target ajoene 
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o 2NADPH 2NADP+ 
II 
2 ~S~S-S~ ~. 2~S~S-S~ 
2NADPH 2NADP+ 
2~S~S-S~ ~. 2 ~S~SH + 2HS~ 
2 ~S~SH + 2HS~ 
~S~S_S~S~ 2 S~ 
In conclusion, the evidence from this study provides important information on the mechanism by 
which ajoene inhibits glutathione reductase. 
1.6 Summary 
In summary, the therapeutic benefits of garlic date back to over 5000 years. These include anti-
fungal and prevention of cancer activitites. Modern organic chemistry has played a major role in 
showing that the compound responsible for biological activity in a garlic clove is a thiosulfinate 
called allicin. Allicin's instability causes it to rearrange to a stable compound called ajoene. 
Ajoene posses a variety of biological activities and this chapter has focused more on its 
apoptotic and anti-cancer activities as they are relevant to this thesis. It has been shown that 
ajoene induce apoptosis both in vivo and in vitro. It induced Human Leukaemia Cell-Line (HL-
60) and it also offered strong protection against TPA-promoted carcinogenesis of mouse skin. 
The biological activity of ajoene has been shown to be accompanied by a generation of reactive 
oxygen species and activation of nuclear factor KB. This prompted scientists to investigate and 
analyse the biological mechanism of ajoene. It was found that ajoene interferes with glutathione 
reductase (the enzyme used by humans to combat oxidative stress) and produce reactive 
oxygen species in cancer cells. In addition it was also found that the apoptotic activity of ajoene 
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2.3,1 Cross-coupling approach 
The stereocontrolled synthesis of olefins is of much interest in the synthesis of ajoene as it 
offers a synthetic method that might access the two ZIE-ajoene isomers independently. 
Cross-coupHng reactions offer a stereospecific synthesis of alkenes involving the use of a 
cata lys l in the form of Ni(O), Pd (0), Cu(I) or Fe(II), with the mosl common OI1e involving 
Pd(O)."'" Three major steps are involved in a cross-coupl ing reaction as oxidative addition, 
transmetal lahOO and redtictive elimination, '· wh ich are shown in Figure 29 using one of the 
most common catalysts , Pd(PPh,j;. 
PdIPPh,). 
I 
.;:(' PdIPPh,), R'X , " 
Rcducbvc 
~hm'n":l on .' (PPh,),Pd • • , 
'\ Oxid~livc 
I "ddi:lOn , .' (PPh,),P~ . , 
1 ra n~n'e : ~llatiun 
F;gllle ?9: era ss-coupli nQ , ata tytic 'iC Ie u ",nQ Pa(O)" 
During the cycle, Pd(PPh)). loses two ligands to form a coordmatlvely Ui1saturated form, 
Pd(PPh,,), 7, which undergoes oxidative addition v..ith the aryl, alkenyl , altyl or benzyt hal ide 
R'X to form complex 8. This is followed by a transmetal la tion step with RM in which the R 
(aryl, alkenyl or some alkyl) group is transferred to the metal catalyst (Pd) centre to form 9. 
Different metals M have given rise to different named reaclions. Thus, wi th M = R,Sn as a 
slannane the coupling is called a Stille coupling, as a boronic acid (S(OH),) a Suz:uki 
coup li ng, and if the metal is ZnX a Negishi coupling. Final ly, reductive elimination results in 
the cross-coupled product 10 with regeneration of Pd(PPh,), for further catalysis Variatioos 
on this general mechanism are in abundant supply in the literature in which both metal and 
cata lyst (via the ligands and oxidahoo state of the palladium) can De widely varied. Oxidative 
addition proceeds with retention of stereochemistry with vinyl hal ides but with invers ioo of 
stereochemistry w,th allylic and benzylic halides '''. 07 The reaction has been eKtended from 
C-C bood formation to accommOdate C-Het bond formation where Het = N, a or S in order 
to cover the common heteroatom bonds to caroon. Through the work of Buchwald, Hartwig 
and others a major advance has been to De able 10 cross-couple amines, thiols and alcohols 
directly with aryl and vinyl compounds bearing a leaving group by using more reactive 
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example is shown in Figure 30 for C-N bond formation, in lIIhich the catalytic steps follow the 
same course as with C"C bond formation " 
AI ·NRR· n "" , , .y .... ~' ~(I - II), ' . ..... _x 
Re,luctive \ Oxklillive 




" ' .>---< 
HX.b.se """" • ~ + u.l~e " 
Fillure 30 : shows a use of a ma re ,eact",e catal;"st Pd(P(1- 8u)~, 
which allows a cross cour:"ing of an amille directly. Regarding aJoene. the relevant reachon 
would be a cross-coupling involving a vinyl halide to generate a vinyl sulfide, and recently 
there has been much interest in developing copper-cataIY2:ed cross-coupling reactions for 
this purpose, since copper-catalyzed methods are mild. they tolerate a variety of functional 
groups or substrates and they work extremely well with soft nucleophiles such as sulfur 
Venkataraman'" and co-workers reported a general stereospecific copper-based standard 
protocol in 2004 for the cross-coupling of vinyl iodides and thiols to form vinyl sulfides, 
Scheme 9." This protocol involves the use of [Cu{phen)(PPh,r.JNO, as a catalyst and 1 5 
equlv K,PO" as a base in toluene at reflux 
10 mol% [C u (phen)(PPh3h~ O, 
__ '_5_e.~2~"<~~ __ 
To lu ene ,24h,11 0 'C 
s. II ..... ., I CI'O",,-cC4'* '>;l DT ThDphe ,d ",oj (£)--1 _iodooct""e 
yield = > 99 % 
Both elect roo-rich and electron-poor thiols were easily tolerated by this method This method 
was also found to be selective for sulfur over oxygen and does not need air-sensitive 
additives, Although this protocol was a success, there were some disadvantages such as the 
need to use an a"- and moisture-sensitive copper catalyst wh'lCh must be used in the 
glovebox and at a high catalytic load of 10 mol%. It requires the use o( harsh conditioos in 
terms of a high temperature which can be sensitive to some labite thiols, as well as long 
reacilon times. This method does not mention tolerance towards protected thiols (or 
preparing vinyl sulfides with SPG (SProtecting Group) for use in the synthesis of ajoene 
derivatives, Recently, Cook" and coworkers improved the reactioo conditions that were 
discovered by Venkataraman3.' by using Cut as an air-stable catalyst that is efficient (or vinyl 
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there was also no investigation on the success of the protocol for producing protected 
sulfides. 
Regarding applying these findings to a possible ajoene analogue synthesis, Scheme 10 
below depicts a possible sequence required for accessing a key synthon 15 for ajoene 
derivative synthesis using a cross-coupling method. If formed, 15 would need to be 
deprotected (-PG), sulfenylated to the disulfide and chemoselectively oxidized to target. The 
example of the catalyst used is palladium which is analogues to a use of a copper catalyst. 
R1~Br 
11 
PdL2 R1S~PCh_2 M-5PG R1S~PdL2 
-----.. i • I + MBr 
Oxidative 12 Br Transmetallation 13 SPG 14 






Scheme 1 0: Stereospecific couplinq of a protected thiol 
However, there would be some major challenges too. Firstly, stereodefined vinyl halide / 
allylic sulfide starting materials would need to be accessed. Although there are 
organometallic methodologies for doing this, the overall synthesis would be rather long. 
Secondly, a protecting group (SPG) would need to be found that could be de protected for 
disulfide bond preparation, while be compatible with the cross-coupling conditions. This is a 
feature not covered by the reported methods. Alkali metal/liquid ammonia on an S-benzyl 
group might work to form an enethiolate that could be sulfenylated to generate the disulfide, 
but such conditions would probably be not compatible with the allyl sulfide. Admittedly, other 
PG's could be considered to do the job (eg STrityl), but it was felt that several questions 
remained. 
2.3.2 JJ-Hydrogen elimination of a halide 
In the second approach considered, 15 might be formed via an elimination of the type shown 
in Scheme 11. The starting material would be in principle easy to access via standard 
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R1~SPG 
15 
Scheme 11: Elimination of hydrogen halide to form 15 
However. this approach would involve an E-2 elimination that proceeds via an anti-periplanar 
transition state. Such a stereoelectronically controlled reaction would only render the E-
isomer, as the SPG and CH2SR1 groups would orientate themselves anti in the transition 
state. Thus, the Z-ajoene wouldn't be available using this strategy. Olefination strategies 
also came to mind such as Wittig methodologies, but stereoselectivity and the choice of PG 
suggested that several reactions might need to be tried out. Thus attention was turned to 
the final option, the radical addition approach. 
2.3.3 Radical addition approach 
Radical addition is an important methodology for converting alkynes to alkenes. Early reports 
of the free-radical addition of thiolacetic acid to alkylacetylenes dates back to the late 1940's 
by H. Behringer, H Bader and co-workers.84,86 In mid-1960's, J. A Kampmeier and G Chen 
proceeded with the study on stereochemistry of the free-radical addition of thiolacetic acid to 
1-hexyne.85 The procedure used was to mix the alkyne with thiolacetic acid at 0°. Initiation by 
adding an initiator was not needed but it was concluded that the reaction involves radical 
intermediates. The intermediate acetylthio radical (17) adds regioselectively to the alkyne 
terminus to form a mixture of E- and Z-stereoisomers of the vinyl thioacetate radicals (18, 















R\ (11) )lSH 0 
~ ... >=< + ,)ls' propagation (1B) H propagation H H initiation (20) 11 
(16) RC ::CH ~"'J1 ~'V 
0 0 
----{ 0 
H\ initiation (11) S ASH 
0 
M >=< + )ls· propa gation .. 
R (19)H 
pro pag ation R H 11 
(21 ) 
Scheme 12: Radical addition ofthiolacetic acid to an alk'fT1e.!15 
The vinyl thioacetate radicals (18 and 19) then abstract a hydrogen atom from a second 
thiolacetic acid to form the mono-adduct as a mixture of EIZ geometrical isomers (20, 21) 
and with regeneration of an acetylthio radical for further propagation. It was established that 
excess thiolacetic acid promotes the formation of a di-adduct of structure shown in Figure 
31.85 For example, the use of a 1:3 ratio of alkylacetylene : thiolacetic acid instead of a 1:2 
ratio facilitates the formation of the diadduct. 
SCOCH3 
I 
n- C4 HgC HC H2SC OC H3 
Figure 31: Diaddud ofthiolacetic acid 
In Kampmeier's study of the addition of thiolacetic acid to 1-hexyne in a 2/1 molar ratio to 








I ' He SCOCH3 
cis trans 
Figu-e 32: cis/trans mono-addition adduds 
The mono-adduct mixture was isolated by preparative-scale v.p.c (vapour-phase 
chromatograph) and analysed by 1H NMR in mid-1960's for definitive structural assignments 
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expected for the trans-isomer (JtransAfB = 15.9 Hz, cis = 9.6 Hz). This reaction was noted to 
form a vinylthio fragment of importance to ajoene synthesis and eventually formed the basis 
of the UCT synthetic sequence87a for substituted ajoene synthesis. Kampmeier compared his 
findings to those found by Benkeser in the radical addition of trichlorosilane to 1-heptyne, 
which gave a 75/25 cis/trans adduct ratio. 81 In both cases the cis-isomer was dominant. A 
likely explanation for the cis-stereoselectivity is that both Z- and E-vinyl radicals 18 and 19 
form and presumably can interconvert, but that the Z-radical 18 reacts faster to product in 
view of lower steric hindrance in the transition state, since the incoming thiolacetic acid 
delivering an H atom only clashes with a vicinal H in the Z-case (18) versus a SCOCH 3 for 
the E-case (19). 
2.4 Synthetic analysis of the UCT synthesis 
The key mechanistic step in the UCT synthesis thus became the regioselective radical 
addition of thiolacetic acid to a terminal alkyne to generate a vinyl thioacetate based on the 
known addition of thiolacetic acid to an alkyne. Retrosynthesis of the target disubstituted 
ajoene is summarized in Scheme 13. 
o 
~ 















Scheme 13: Retros~hesis of a disubstituted ajoene 
The individual steps will now be discussed. The first step involves propargylation of a thiol, 
the latter either commercially available or synthesized via thiourea chemistry, which involved 

















R1~SH + ~Br 
26 28 











Scheme 14: Preparation ofthe alkylated thiol 
Hydrolysis of the salt 24 occurs with KOH to give an odorous thiol 26 with the formation of 
potassium chloride and release of urea 27. Rather than isolate an odorous thiol, it was 
alkylated in situ with propargyl bromide 28 to furnish alkynyl sulphide 29, which could be 
isolated via an extractive work-up followed by either distillation or chromatography 
depending on the nature of R1. Compound 29 was then reacted with thiolacetic acid using 
1,1 '-azobis(cyclohexanecarbonitrile} as a radical initiator (catalytic amount). The mechanism 
of this reaction follows the normal initation, propagation, termination sequence typical of 














28) Propa gation 
2b) Propagation 
3) Temination 
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N~U.~ 0 
-N#leat ~ l II 
• + H"0~ 
o 
.Jl. s 
31 32 33 
y~~l 
o 34 33 29 
0 0 





0 34 32 35 
0 0 0 0 
.~ s + 'A s ~-sA.. 
33 33 
36 
Schewe 15: Mechanism forthe radical addition reaction 
33 
The vinyl thioacetate 35 is then elaborated by deprotecting it with KOH in methanol at low 
temperature to form an enethiolate 37, Subsequent addition of an appropriately substituted 




Thiosulfonate 38 acts as a soft sulfenylating agent towards the enethiolate anion with the 
expUlsion of sulfinate ion, 
In the final step of the sequence compound 39 is chemoselectively oxidized to the sulfoxide 
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nucleophilic sulfur of the three available, which is the sulfide sulfur. The double bond is also 
left intact, Scheme 17. 
m-CPBA o 
40 II ----""""1..... R( .. S~S .... s~R2 
CH2 C12/-78 °C - rt 41 
Scheme 17 
2.5 Objectives 
This project was aimed at synthesizing a small library of ajoene analogues for biological 
evaluation containing the central vinyl disulphide/sulphoxide core while varying the end 
groups R1/R2 as shown in Figure 33. It was carried out as part of a broader study within the 
group at UCT. 
In conjunction with the broader study, the following four derivatives were targeted for 
synthesis, inclusion studies into [3-cyclodextrin and biological evaluation. 
o 
~g~s,s~ 
Figure 34: Com pounds for study in thisthesis 
The project was thus divided into three parts: 
• The synthesis of substituted ajoene derivatives shown in Figure 34 
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Chapter 3: Experimental Section 
4-Methoxybenzyl-2-propynyl sulfide 887a 
Meo~ 1 
:~~y 
7 5 3 
Experimental 
Thiourea (2.67 g, 35.0 mmol) was dissolved in acetonitrile (25 ml), and 4-methoxybenzyl 
chloride (5.00 g, 31.9 mmol) was then added dropwise. The mixture was subsequently 
refluxed for 40 min, then cooled in ice and the precipitated product filtered and washed with 
cold acetonitrile. The washed salt (7.02 g, 30.2 mmol) was then added to a stirred ice-cooled 
solution of KOH (4.81 g, 67.4 mmol) in methanol (12 ml) to produce an odorous product and a 
solid (KCI) precipitate. Propargyl bromide (4.82 g, 32.4 mmol, 80% in toluene) was added 
dropwise to this solution and the reaction allowed to stir at room temperature for 2 h. TLC (3% 
ethyl acetate in hexane) showed a spot-to-spot conversion to a more polar product that was 
UV-active. The methanol solvent was removed under vacuum and the residue suspended in 
CH2CI2 , which was shaken with water (20 ml), the organic layer separated and dried (MgS04), 
filtered and the solvent evaporated to dryness under reduced pressure to give a light yellow 
oil. The residue was purified on a silica-gel column using 3% ethyl acetate in petroleum ether 
as eluent to give 8 as a light-yellow oil (3.86 g, 66%): Vmax / cm-
1 3282 (HC=C), 663 (C-S); DH 
(400 MHz, CDCI3) 2.25 (1 H, t, J, 2.6 Hz, H-1), 3.04 (2H, d, J 2.6 Hz, H-3), 3.77 (3H, s, -OMe), 
3.80 (2H, s, H-5), 6.84 (2H, d, J 8.8 Hz, H-8), 7.24 (2H, d, J 8.8 Hz, H-7); Dc (100 MHz, 
CDCI3), 18.3 (C-3), 34.6 (C-5), 55.3 (OMe), 71.2 (C-1), 79.9 (C-2), 113.9 (C-8), 129.3 (C-6), 
130.1 (C-7), 158.8 (C-9); HRMS (EI): m/z 193.0701 [M+Hr, C11 H130S requires 193.0687. 
EIZ-S-3-(4-Methoxybenzylthio )-prop-1-enyl ethanethioate 14 
MeoQ 
12 I 7 5 3 1 
11 ~9 S~s~ 
10 8 6 4 II 
° 
Thiolacetic acid (1.30 g, 17.2 mmol), was added with a dropping funnel to a solution of alkyne 
8 (3.00 g, 15.6 mmol) and 1,1'-azobis(cyclohexanecarbonitrile) (190 mg). The mixture was 
refluxed in toluene at 80°C over a period of about 2 h under N2 • Toluene was then removed 
under vacuum and the residue dried on a pump to give a yellow oil which was purified directly 
on a silica-gel column using 5% ethyl acetate in petroleum ether as eluent to give compound 
14 as a 3:2 mixture of ZlE stereoisomers (2.32 g, 83% yield based on 991 mg compound 8 
recovery): Vmax / cm-
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3.09 (2H, dd, J 1.0, 7.4 Hz, H-6), 3.63 (2H, s, H-8), 3.78 (3H, s, -OMe), 5.84 (1 H, dt, J 7.4,9.5 
Hz, H-5), 6.65 (1H, dt, J 1.0,9.5 Hz, H-4), 6.84 (2H, d, J8.3 Hz, H-11), 7.19 (2H, d, J8.3 Hz, 
H-10); iSc(100 MHz, CDCI3), 30.8 (C-1), 33.2. (C-6), 35.2 (C-8), 55.4 (-OMe), 113.9 (C-11), 
119.3 (C-5), 128.6 (C-4), 130.1 (C-9), 130.2 (C-1 0), 158.7 (C-12), 191.2 (C-2). 
E-14 iSH (400 MHz, CDCI3) 2.35 (3H, s, H-1), 3.08 (2H, dd, J 1.1, 7.4 Hz, H-6), 3.62 (2H, s, H-
8),3.78 (3H, s, -OMe), 5.80 (1H, td, J 7.4,15.2 Hz, H-5), 6.49 (1H, dt, J 1.1,15.2 Hz, H-4), 
6.81 (2H, d, J 8.7 Hz, H-11), 7.22 (2H, d, J 8.7 Hz, H-10); iSc(100 MHz, CDCI3), 30.7 (C-6), 
30.9 (C-1), 34.4 (C-8), 55.4 (-OMe), 113.9 (C-Ar), 119.6 (C-5), 129.9 (C-9), 130.2 (C-10), 
130.4 (C-4), 158.7 (C-12), 191.2 (C-2); HRM8 (EI): m/z 307.0404 [M+NaO], C13H16Na0382 
requires 307.0439. 
EIZ-1 0-(4-Methoxyphenyl)-4,5,9-trithiadeca-1 ,6-diene 20 
KOH (509 mg, 9.08 mmol) was dissolved in methanol (15 ml) at 0° C and added dropwise to 
thioate ester 14 (2.00 g, 7.46 mmol) in methanol (5 ml) at -30°C under N2. The reaction was 
left stirring for 20 min before cooling to -78°C, whereupon S-prop-2-enyl 4-
methylbenzenesulfonothioate87b (1.74 g, 7.60 mmol) dissolved in MeOH (5.0 ml) was added 
slowly dropwise. The reaction was allowed to warm to O°C and left stirring for 3 h before 
quenching with aqueous ammonium chloride (20 ml). Water (40 ml) was added and the 
product was then extracted with CH2Cb (3 x 50 ml). The CH2CI2 layer was washed with 
saturated NaCI solution (2 x 20 ml), dried and reduced under vacuum. The resultant yellow 
liquid was purified on a silica-gel column using 5% ethyl acetate in petroleum ether to give 
compound 20 as a 2:3 mixture of ZlE geometrical stereoisomers (1.87 g, 84 % yield): Vmax / 
cm-1 3079 (C-H aromatic), 2913 (C-H aliphatic), 1508 (C=C), 659 (8-C), 470 (8-8); Z- 20 iSH 
(400 MHz, CDCI3) 3.19 (2H, dd, J 1.0, 7.5 Hz, H-8), 3.34 (2H, m , H-3), 3.66 (2H, s, H-10), 
3.78 (3H, s, OMe), 5.14 (2H, m, H-1), 5.66 (1H, dt, J7.5, 9.2 Hz, H-7), 5.84 (1H, m, H-2), 6.21 
(1H, dt, 1.0,9.2 Hz, H-6), 6.84 (2H, d, J 8.6 Hz, H-Ar), 7.20 (2H, d, J 8.6 Hz, H-Ar); iSc(100 
MHz, CDCI3), 32.7 (C-8), 34.6 (C-10), 42.1 (C-3), 55.2 (-OMe), 113.9 (C-Ar), 119.0 (C-1), 
128.0 (C-Ar), 128.1 (C-Ar), 130.0 (C-2), 130.1 (C-7), 132.8 (C-6), 158.6 (C-Ar). 
E-20 iSH 3.06 (2H, dd, J 1.0,7.3 Hz, H-3), 3.34 (2H, m, H-3), 3.62 (2H, s, H-10), 3.79 (3H, S,-
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d, J 8.6 Hz, H-Ar), 7.20 (2H, d, J 8.6 Hz, H-Ar); Oc(100 MHz, CDCI3), 29.4 (C-8), 35.4 (C-10), 
41.3 (C-3), 55.2 (-OMe), 114.0 (C-Ar), 119.0 (C-1), 128.0 (C-Ar), 128.1 (C-Ar) 128.2 (C-2), 
130.7 (C-7), 132.8 (C-6), 158.6 (C-Ar); HRMS (EI): m/z 225.0436 [M-C3H5Sr, C11H130S2 
requires 225.0408. 
E/z-1 O-(4-Methoxyphenyl)-4,5,9-trithia-deca-1 ,6-diene 9-oxide 25 
A solution of m-CPBA (421 mg, 1.89 mmol) in CH2CI2 (3.0 ml) was added dropwise to 
compound 20 (535 mg, 1.79 mmol) dissolved in CH2CI2 (5 ml) cooled to -78°C. The reaction 
was allowed to warm to room temperature and left stirring for 3 h, before quenching with 
saturated aqueous sodium bicarbonate (20 ml) and extracting with ethyl acetate (3 x 30 ml). 
The organic extracts were dried with MgS04 and the solvent evaporated. The residue was 
then purified on a silica-gel column using 40% ethyl acetate in petroleum ether as eluent to 
give compound 25 (467 mg, 83%) as a 2:3 mixture of ZlE geometrical stereoisomers: vmax / 
cm 3007 (C-H aromatic), 2826 (C-H aliphatic), 1512 (C=C), 1013 (S=O), 663 (C-S), 450 (S-S); 
Z-25 OH (CDCI3, 400 MHz) 3.34 (2H, d, J 7.2 H-3), 3.40(1H, ddd, 1.1,7.8, 13.3, Hz, H-8a), 
3.43 (1H, ddd, 1.1,7.8,13.3, Hz, H-8b), 3.78 (3H, s, OMe), 3.90 (2H, s, H-10), 5.14 (2H, m, 
H-1), 5.80 (2H, m, H-2, H-7), 6.54 (1 H, dt, J 1.1, 9.8, Hz, H-6), 6.88 (2H, d, J 8.8 Hz, H-13), 
7.20 (2H, d, J 8.8 Hz, H-12); Oc (CDCI3, 100 MHz) 42.1 (C-3), 49.6 (C-8), 55.3 (OMe), 56.9 (C-
10) 114.5 (C-13), 118.4 (C-7), 119.2 (C-1), 121.7 (C-11) 131.2 (C-12), 132.6 (C-2), 138.2 (C-
6), 159.8 (C-14). 
E-25 OH (CDCI3, 400 MHz) 3.27 (1 H, ddd, J 1.1, 8.0, 13.2 Hz, H-8a), 3.27 (2H, d, J 7.6 Hz H-
3), 3.51(1H, ddd, J 1.1, 8.0,13.2, Hz, H-8b), 3.79 (3H, s, -OMe), 3.90 (2H, s, H-10), 5.18 (2H, 
m, H-1), 5.80 (1H, m, H-2), 5.92 (1H, dt, J 8.0,15.0, H-7), 6.32 (1H, dt, J 1.1,15.0, H-6), 6.88 
(2H, d, J 8.8, Hz, H-13), 7.21 (2H, d, 8.8 Hz, H-12); oc(CDCI3, 100 MHz) 41.3 (C-3), 52.8 (C-
8),55.3 (OMe), 56.3 (C-10) 114.5 (C-13), 117.3 (C-7), 119.2 (C-1), 121.5 (C-11), 131.2 (C-
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Potassium hydroxide (19.4 g, 340 mmol) was dissolved in degassed methanol (30 ml) and the 
mixture cooled to 00 C under N2• 1-Propanethiol (20.0 g, 263 mmol) was added dropwise 
slowly followed by propargyl bromide (41.0 g, 276 mmol, 80% in toluene) and the reaction 
allowed to proceed at room temperature for 6 h. TLC (hexane) showed a spot-to-spot 
conversion to a more polar product that was UV active. The methanol solvent was then 
removed on the rotoevaporator under water pressure and the residue suspended in diethyl 
ether (40 ml), which was washed with water (3 x 10 ml). The ether extract was dried with 
MgS04, filtered and the solvent removed on the rotorevaporator keeping the bath temperature 
low. The resultant residue was purified by distillation at 1500 C at atmospheric pressure to 
give 28 (23.9 g, 80 %) as an orange oil: Vmax / cm-
1 3290 (HC=C), 2955 (C-H aliphatic), 638 
(C-S); OH (400 MHz, CDCI3) 1.00 (3H, t, J 7.3 Hz, H-7), 1.63 (2H, m, H-6), 2.21 (1 H, t, J 2.6 
Hz, H-1), 2.66 (2H. t, J 7.3 Hz, H-5), 3.23 (2H, d, J 2.6 Hz, H-3); Oc (100 MHz, CDCI3) 13.4 
(C-7), 19.0 (C-3), 22.3 (C-6), 33.6 (C-5), 70.7 (C-1), 80.1 (C-2). 
S-1-(4-Thiahept-1-enyl) ethanethioate 29 
9 7 5 3 1 
~s~s-..y 
10 8 6 4 II 
o 
Thiolacetic acid (7.35 g, 96.6 mmol), alkyne 28 (10.0 g, 87.6 mmol) and 1,1 '-
azobis(cyclohexanecarbonitrile) (2.14 g, 8.76 mmol) were refluxed in toluene at 80°C under N2 
for 2 h. Toluene was then removed under vacuum and the residue dried on a vacuum pump to 
give an orange oil, which was purified directly on a silica-gel column using neat petroleum 
ether as eluent to give compound 29 (9.80 g, 80 % based on recovery of 2.64g of alkyne 28) 
as a 3:2 mixture of ZlE stereoisomers: Vmax / cm·
1 2957 (C-H), 1698 (C=O), 634 (C-S); Z-29 OH 
(400 MHz, CDCI3) 0.95 (3H, t, J 7.4 Hz, H-10), 1.60 (2H, m, H-9), 2.37 (3H, s, H-1), 2.41 (2H, 
t, J 7.3 Hz, H-8), 3.16 (2H, dd, J 1.3,7.8 Hz, H-6), 5.85 (1H, dt, J 7.8,10.4 Hz, H-5), 6.65 (1H, 
dd, J 1.3,10.4 Hz, H-4); Oc(100 MHz, CDCI3), 13.4 (C-10), 22.8 (C-9), 30.8 (C-1), 31.0 (C-6), 
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E-29 OH (400 MHz, CDCI3), 0.96 (3H, t, J 7.4 Hz, H-10), 1.60 (2H, m, H-9), 2.32 (3H, s, H-1), 
2.41 (2H, t, J 7.3 Hz, H-8), 3.21 (2H, dd, J 1.3, 7.8 Hz, H-6), 5.80 (1 H, dt, J 7.8, 15.7 Hz, H-5), 
6.52 (1H, dt, J 1.3, 15.7 Hz, H-4); Oc(100 MHz, CDCI3), 13.4 (C-10), 22.6 (C-9), 30.5 (C-1), 
33.0 (C-8), 34.0 (C-6), 118.8 (C-4), 130.5 (C-5), 192.8 (C-9); HRMS (EI): m/z 190.0485 [Mr, 
CSH140S2 requires 190.0486. 
(E,Z)-4,5,9-trithia-dodeca-1 ,6-diene 40 
11 9 7 5 3 1 
/"/S~S'S~ 
12 10 8 6 4 2 
KOH (1.44 g, 25.2 mmol) was dissolved in methanol (20 ml) at O°C and added dropwise to 
thioate ester 29 (2.40 g, 12.6 mmol) in methanol (10 ml) at -30'C under N2. The reaction was 
left stirring for 20 min before cooling to -78'C, whereupon S-prop-2-enyl 4-
methylbenzenesulfonothioateSSb (2.94 g, 12.9 mmol) in methanol (5.0 ml) was added 
dropwise. The reaction was allowed to warm to O'C and left stirring for 2 h before quenching 
with aqueous ammonium chloride (20 ml). Water (40 ml) was added and the product was then 
extracted with CH2CI2 (3 x 50 ml). The CH2Cb extracts were washed with saturated brine 
solution (2 x 20 ml), dried and reduced under vacuum. The resultant orange liquid was 
purified on a silica-gel column using petroleum ether as eluent to give compound 40 as a 3:2 
mixture of ZlE geometrical stereoisomers (2.46 g, 89% yield); Z-40 OH (400 MHz, CDCI3) 0.99 
(3H, t, J 7.3 Hz, H-12), 1.63 (2H, m, H-11), 2.48 (2H, t, J 7.3 Hz, H-10), 3.27 (2H, dd, J 1.1, 
7.4 Hz, H-8), 3.37 (2H, m, H-3), 5.18 (2H, m, H-1), 5.69 (1H, dt, J 7.4,9.7 Hz, H-7), 5.87 (1H, 
m, H-2), 6.23 (1 H, dt, J 1.1, 9.7 Hz, H-6); oc(100 MHz, CDCI3), 13.5 (C-12), 23.0 (C-11), 29.5 
(C-8), 33.4 (C-1 0), 42.1 (C-3), 118.9 (C-1), 128.7 (C-7), 131.7 (C-6), 132.9 (C-2). 
E-40 OH (400 MHz, CDCI3), 0.99 (3H, t, J 7.3 Hz, H-12), 1.60 (2H, m, H-11), 2.45 (2H, t, J 7.3 
Hz, H-10), 3.19 (2H, dd, J 1.2, 7.7 Hz, H-8), 3.35 (2H, m, H-3), 5.17 (1 H, d, J 8.9 Hz, H-1 
trans), 5.29 (1H, d, J 16.8 Hz, H-1 cis), 5.86 (2H, m, H-2, H-7), 6.11(1H, dt, J 1.2,14.6 Hz, H-
6); Oc(100 MHz, CDCI3), 13.5 (C-12), 22.7 (C-11), 33.1 (C-10), 33.5 (C-8), 41.3 (C-3), 118.9 
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(E,Z)- 4,5,9-Trithia-dodeca-1 ,6-diene 9-oxide 43 
o 
11 II 7 
~S~6 
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43a 43b 
m-CPBA (396 mg, 2.30 mmol) was dissolved in CH2CI2 (5 ml) and added dropwise to 
compound 40 (460 mg, 2.09 mmol) in CH2CI2 (5 ml) at -78°C under N2. The reaction was 
allowed to warm to room temperature and left stirring for 3 h, before quenching with saturated 
aq. sodium bicarbonate (15 ml) and extracting with ethyl acetate (3 x 30 ml). The organic 
extracts were dried with MgS04, and the solvent removed under vacuum. The resultant 
residue was then purified on a silica-gel column using 40% ethyl acetate in petroleum ether as 
eluent to give compound 43 (400 mg, 82%) as a 3:2 mixture of ZlE geometrical 
stereoisomers. These could be separated by slow column chromatography. 
Z-43a IR vmax (neat) / cm-\ 1368 (C=C), 1018 (S=O), 651 (C-S), 450 (S-S); OH (400 MHz, 
CDCI3) 1.08 (3H, t, J 7.3 Hz, H-12), 1.81 (2H, m, H-11), 2.61 (1H, dt, J 8.2,13.7 Hz, H-10a), 
2.71 (1 H, dt, J 8.2, 13.7 Hz, H-1 Ob), 3.37 (2H, m, H-3), 3.56 (1 H, dd, J 8.1, 13.2, Hz, H-8a), 
3.63 (1H, dd, J 8.1,13.2, Hz, H-8b), 5.16 (2H, m, H-1), 5.76 (1H, dt, J 8.1,9.2, Hz, H-7), 5.84 
(1 H, m, H-2), 6.54 (1 H, d, J 9.2 Hz, H-6); oc(100 MHz, CDCI3), 13.4 (C-12), 16.2 (C-11), 42.1 
(C-3), 50.9 (C-8), 53.5 (C-1 0), 118.5 (C-7), 119.2 (C-1), 132.6 (C-2), 138.2 (C-6). 
E-43b IR Vmax (neat) / cm-
1 1400 (C=C), 1018 (S=O), 644 (C-S), (S-S). OH (400 MHz, CDCI3), 
1.06 (3H, t, J 7.3 Hz, H-12), 1.80 (2H, m, H-11), 2.61 (2H, m, H-10), 3.33 (2H, m, H-3), 3.43 
(1H, dd, J 7.9, 13.2 Hz, H-8a), 3.51 (1H, dd, J 7.9, 13.2 Hz, H-8b), 5.15 (2H, m, H-1), 5.82 
(1H, m, H-2), 5.91 (1H, dt, J 7.9, 14.6 Hz, H-7), 6.34 (1H, d, J 14.6, H-6); Oc (100 MHz, 
CDCI3), 13.3 (C-12), 16.1 (C-11), 41.2 (C-3), 53.0 (C-10), 54.5 (C-8), 117.1 (C-7), 119.1 (C-1), 
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S-Propyl 4-methylbenzenesulfonothioate 3488b 
10 
~ 8~~9 3 1 
7 II 'S~ 
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Potassium p-toluenethiosulfonate (7.18 g, 31.7 mol) was dissolved in DMF (10 ml) and a 
solution of 1-bromopropane (3.00 g, 24.4 mmol) added dropwise. The reaction was then left 
stirring at room temperature for 3 h before quenching with saturated aq. sodium bicarbonate 
(30 ml) and extracting with CH2Cb (3 x 30 ml). The extracts were dried with MgS04 and the 
solvent reduced under vacuum. The residue was then purified on a silica-gel column using 5% 
ethyl acetate in petroleum ether as eluent to give compound 34 (7.02 g, 96%). OH (400 MHz, 
CDCI3) 0.93 (3H, t, J 7.4 Hz, H-1), 1.64 (2H, m, H-2), 2.45 (3H, s, H-10), 2.97 (2H, t, J 7.3 Hz, 
H-3), 7.34 (2H, d, J 8.3 Hz, H-Ar), 7.81 (2H, d, J 8.3 Hz, H-Ar); oc(100 MHz, CDCI3) 13.1 (C-
1), 21.6 (C-10), 22.2 (C-2), 37.9 (C-3), 126.9 (C-Ar), 129.8 (C-Ar), 142.2 (C-Ar), 144.6 (C-Ar). 
(E,Z)-4,5,9-Trithia-dodeca-6-ene 41 
11 9 7 5 3 1 
/"'-./S~S'S~ 
12 10 8 6 4 2 
KOH (1.44, 25.2 mmol) was dissolved in methanol (20 ml) at O°C and added dropwise to 
thioate ester 29 (4.00 g, 21.0 mmol) in methanol (10 ml) at -30'C under N2. The reaction was 
left stirring for 20 min before cooling to -78'C, whereupon sulfenylating agent 34 (4.94 g, 21.4 
mmol) in methanol (5.0 ml) was added dropwise. The reaction was allowed to warm to O'C 
and left stirring for 4 h before quenching with aqueous ammonium chloride (20 ml). Water (40 
ml) was added and the product was then extracted with CH2Cb (3 x 50 ml). The CH2CI2 layer 
was washed with saturated brine (2 x 20 ml), dried and reduced under vacuum. The resultant 
orange liquid was purified on a silica-gel column using petroleum ether as eluent to give 
compound 41 (2.70 g, 76 % yield based on the recovery of 986 mg of starting material 29) as 
a 2:3 ZlE mixture of geometrical stereoisomers Z-41 OH (400 MHz, CDCI3) 0.97 (3H, t, J 7.3 
Hz, H-1), 0.99 (3H, t, J 7.3 Hz, H-12), 1.61 (2H, m, H-11), 1.69 (2H, m, H-2), 2.47 (2H, t, J 7.4 
Hz, H-10), 2.70 (2H, t, J7.1 Hz, H-3), 3.26 (2H, dd, J 1.3,7.4 Hz, H-8), 5.66 (1H, dt, J7.4, 9.3 
Hz, H-7), 6.23 (1H, dt, J 1.3,9.3 Hz, H-6); oc(100 MHz, CDCI3) 12.9 (C-1), 13.4 (C-12), 22.2 
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E-41 OH (400 MHz, COCI3) 0.97 (3H, t, J 7.3 Hz, H-1), 0.99 (3H, t, J 7.3 H-12), 1.61 (2H, m, H-
11), 1.69 (2H, m, H-2), 2.43 (2H, t, J 7.4 Hz, H-10), 2.68 (2H, t, J 7.1 Hz, H-3), 3.17 (2H, dd, J 
1.3, 7.7 Hz, H-8), 5.86 (1 H, dt, J 7.7, 14.8 Hz, H-7), 6.11 (1 H, dt, J 1.3, 14.8 Hz, H-6); oc(100 
MHz, COCI3) 13.0 (C-1), 13.4 (C-12), 22.3 (C-2), 22.6 (C-11), 32.9 (C-10), 33.5 (C-8), 40.4 (C-
3),127.8 (C-7), 128.2 (C-6). ; HRMS (EI): m/z 222.0566 [Mr, C9H1SS3 requires 225.0571. 
(E,Z)- 4,5,9-Trithia-dodeca-6-ene 9-oxide 44 
o 
11 II 7 
~S~6 
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44b 
m-CPBA (1.70 g, 9.85 mmol) was dissolved in OCM (5 ml) and added dropwise to compound 
41 (2.00 g, 8.94 mmol) at -78°C in OCM (10 ml). The reaction was allowed to warm to room 
temperature and left stirring for 2 h, before quenching with saturated aq. sodium bicarbonate 
(15 ml) and extracting with ethyl acetate (3 x 30 ml). The product was dried with MgS04 and 
the solvent dried and reduced under vacuum. The residue was then purified on a silica 
column using 50% ethyl acetate in petroleum ether as eluent to give compound 44 (1.11 g, 
52%) as a 2:3 mixture of ZlE geometrical stereoisomers; Z-44a OH (400 MHz, COCI3) 0.99 
(3H, t, J7.3 Hz, H-1), 1.08 (3H, t, J7.3 Hz, H-12), 1.70 (2H, m, H-2), 1.80 (2H, m, H-11), 2.65 
(4H, m, H-3, H-10), 3.52 (1H, dd, J 7.6, 13.4 Hz, H-8a), 3.63 (1H, dd, J 7.6, 13.4 Hz, H-8b), 
5.75 (1H, dt, J7.6, 9.5 Hz, H-7), 6.56 (1H, d, J9.5 Hz, H-6). oc(100 MHz, COCI3) 12.9 (C-1), 
13.4 (C-12), 16.2 (C-2), 22.3 (C-11), 41.3 (C-3), 50.9 (C-8), 53.4 (C-10), 118.0 (C-7), 138.7 
(C-6). 
E-44b OH (400 MHz, COCI3) 0.99 (3H, t, J 7.3 Hz, H-1), 1.08 (3H, t, J 7.3 Hz, H-12), 1.70 (2H, 
m, H-2), 1.80 (2H, m, H-11), 2.65 (4H, m, H-3, H-10), 3.45 (1 H, dd, J 7.8, 13.0 Hz, H-8a), 3.52 
(1H, dd, J 7.8,13.0 Hz, H-8b), 5.93 (1H, dt, J 7.8,15.0 Hz, H-7), 6.37 (1H, d, J 15.0 Hz, H-6); 
oc(100 MHz, COCI3), 13.0 (C-12), 13.4 (C-1), 16.2 (C-2), 22.4 (C-11), 40.4 (C-3), 53.1 (C-10), 
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E-13 OH (400 MHz, CDCI3) 0.98 (3H, t, J 7.4 Hz, H-10), 1.60 (2H, m, H-9), 2.40 (3H, s, H-1), 
2.46 (2H, t, J 7.4 Hz, H-8), 3.20 (2H, dd, J 1.0, 7.4 Hz, H-6), 5.90 (1 H, dt, J 7.4, 14.6 Hz, H-5), 
6.11 (1H, dt, J 1.0,14.6, Hz, H-4); oc(100 MHz, CDCI3) 13.5 (C-10), 22.2 (C-1), 22.7 (C-9), 
33.1 (C-8), 33.5 (C-6), 126.4 (C-5), 128.5 (C-4). ; HRMS (EI) m/z 194.0248 [Mr, C7H14S3 
requires 194.0258. 
(E,Z)-2,3, 7 -Trithia-deca-4-ene 7 -oxide 45 
o 
9 II 5 
~S~4 
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S-Methyl 4-methylbenzenesulfonothioate 35 
Potassium p-toluenethiosulfonate (7.18 g, 31.7 mmol) was dissolved in DMF (10 ml), which 
was then added dropwise to a solution of iodomethane (3.45 g, 24.4 mmol). The reaction was 
then left stirring at room temperature for 3 h before quenching with saturated aq. sodium 
bicarbonate (30 ml) and extracting with CH2Cb (3 x 30 ml). The organic extracts were dried 
with MgS04 , and the solvent dried and reduced under vacuum. The residue was then purified 
on a silica column using 5% ethyl acetate in petroleum ether as eluent to give compound 35 
(6.15 g, 96%). OH (400 MHz, CDCI3) 2.43 (3H, s, H-1), 2.48 (3H, s, H-8), 7.33 (2H, d, J 8.2 Hz, 
H-Ar), 7.78 (2H, d, J 8.4 Hz, H-Ar); oc(100 MHz, CDCI3) 17.9 (C-8), 21.5 (C-1), 127.0 (C-Ar), 
129.8 (C-Ar), 140.8 (C-Ar), 144,7 (C-Ar) 
(E,Z)-2,3, 7 -Trithia-4-decene 42 
9 75 3 1 
~S~S'S/ 
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Chapter 4: Results and Discussion 
With a versatile synthesis available, the first objective identified was to change just one of the 
end groups of ajoene, while retaining the other as allyl. The group chosen for change was the 
one on the sulfoxide end and the studies in this MSc thesis contributed to a broader study of 





Figure 35 : General structure of target for structure-activity study 
That way, a rational structure-activity study could be undertaken while retaining the vinyl allyl 
disulfide I sulfoxide core believed to be the main pharmacophore in the molecule. Biological 
evaluation would involve measuring the anti-cancer activity against CT-1 transformed 
fibroblast cells as well as an oesophageal cancer cell-line with individual E- and Z-ajoene 
isomers as the reference standard. For any drug development it is important to increase the 
bioavailability of the lead in aqueous media. Thus, inclusion of these derivatives into a 
cyclodextrin presented itself as a worthwhile objective. 
The project was thus divided into three parts: 
• The synthesis of suitably modified ajoene derivatives 
• inclusion of the synthesized ajoene derivatives into cyclodextrin 
• biological evaluation of the ajoene derivatives as anti-cancer agents. 
The tools used for purification and separation of these compounds were silica-gel column 
chromatography and preparative TLC plates. 1H NMR, 13C NMR, IR and mass spectroscopy 
were used as spectroscopic and analytical tools for confirming the structures of the 
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4.1 Synthesis of Ajoene derivatives 
The first target that was envisaged is depicted in Figure 36 as compound 18. 
18 
Figure 36: structure ofthe targeted ajoene derivative 
The para-methoxybenzyl substituent of 18 was chosen due to its lipophilicity as well as for 
studying the influence of an electron-rich aromatic ring. It was also readily incorporated into 
the synthetic sequence from a commercial source. Thus, the synthesis of 18 began with 
propargylation of p-methoxybenzyl thiol. Since the latter was not available, its preparation 
was undertaken using the well-known thiourea chemistry on the commercially available 
chloride 1.87a 
This involved refluxing thiourea 2 (1.1 equivalents) in acetonitrile with p-methoxybenzyl 
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Scheme 18: Prep aratio n of the alkylated salt 
The reaction afforded a salt that would only migrate up a tic plate in very polar mobile systems 
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be followed by the disappearance of chloride 1 and was oomplete after 40 min. On oooling, 
the product that crystallised was filtered and then wasMd with oold acetonitril€. The 
crystal li ne salt was then dissolved in methanot and hydrolysed with KOH to the odorous thiolS 
with the formatIOn of potassium chloride and urea 6. Rather than isota te an odorous thiol. it 
was decided to alkylate in sifu with propargyl bromide 7, which was added directly to the 
med ium . Two equivalents of KOH were added overall one for the satt hydrolysis and the 
other for neutralis ing the HBr from the alkylation. After 2 hrs, ti c indicated the formation of a 
non-polar sulphide that was isolated by extract ion. Column chromatography afforded 
compound 8 as a yellow oi l in 66% yield over the two steps based on chloride 1. Figure 37 
shows tM 'H NMR spectrum for oompound 8 with all the expected resonances Traces of 
ethy1 acelate nol removed in vac;uo can be identified. 
"'·'v"'. , 
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. , 
A __ 
Fiqure38; Partion of ' H NMR spectrum 018 
The structure of compound 8 was confirmed by the presence of an alkyne methine hydrogen 
triplet in the 'H NMR spectrum at 2.25 ppm due to long-range coupling with the propargylic 
methylene (H-3). In tum, H-3 was a doublet. Other diagnostic signals included a singlet due to 
the benzylic methylene allylic H-5 (3.80 ppm) as well as an AB pair for the 1 4-disubstituted 
phenyl ring (6.84 and 7.24 ppm). Figure 38 show the multiplicities for H-1 and H-3, which 
serve to confirm the success of the reaction to afford compound 8 (Figure 37). 
In addition, two resonances for a triple bond in the "c NMR spectrum at 71 2 ppm and 79.9 
ppm confirmed propargylation Finally, mass spectrometry was used as a tool to confirm the 
synthesis of compound B Mass-spectrometry works by using magnetic and electric f<elds to 
exert force on charged particles in a vacuum Therefore, the compounds must be charged or 
ionized and must be introduced in a gaseous phase. A beam of electrons acceterated from a 
filament. usually to an energy of about 70eV' passes through the sample and an electron 
col lides With a neutral analyle molecule which krKlcks out an electron resulting in a positively 
charged ion " This Involves the ionization energy and is termed electron-impact ionization. 
The ionization impact may either produce a molecular ion which will have the same molecular 
weight and etementary compoSition as the starting material or it can produce a fragment ion 
which corresponds to a smaller piece of the analyte. Other ionization techniques involve 
electrospray (ES) and Fast Atom Bombardment (FAB) techniques. In the FAB techmque an 
anatyte is dissolved in a liquid matrix such as glycerol, th ioglycerol, m-nitrobenzyl atcohol or 
dlethanolamine. A smatl amount of the solution is placed on a target or emitter. The target is 
then bombarded With a fast atom beam, for example 6keV Xenon atoms that desorb 
molecular-l ike ions and fragments from the analyte Cluster ions from that liq uid matrix are 
also desorbed to produce a chemical background that vanes with the matrix used By 
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across a high potential difference from the needle into the orifice in the interface. Heat and 
gas are used to desolvate the ions existing in the sample solution. This ionization technique 
can produce multiple charged ions with the number of charges tending to increase as the 
molecular weight increases. 
A high-resolution mass spectrum run using electrospray (ES) gave definitive evidence in 
support of 8. The exact mass for compound 8 in a protonated form is 193.0687 and the mass 
spectrum was in accordance with this value recording a mass of 193.0701 as shown in Figure 
39, as an [M+Hr ion within experimental error (14 in 10,000 is acceptable). 
Show more of these in other places 




7 5 3 
Chemical Formula: C11H1~S 
E)(a ct Mass: 193.0687 
m/z: 19307 (100.0%), 19407 (12.9%), 195.06 (45%) 
ElementalAnalysis: C,6835. H,6.78; 0,8.28; S. 1659 
Figure 39 
The next step involved a radical addition of thiolacetic acid to the triple bond of compound 8 
using 1,1 '-azobis( cyclohexanecarbonitrile) 9 as a radical initiator. The latter was added at 
catalytic levels of about 0.05 equivalents although the fact that it is consumed in the reaction 
therefore means that it is not a catalyst. The first step was to dissolve alkyne 8 and radical 
initiator 9 in degassed toluene under N2. Thiolacetic acid (1.1 eq) was then added dropwise 
with a dropping funnel to the solution at about 80°C over a period of about two hours, 
which is a high enough temperature for initiation to occur. Thereafter, the mixture was refluxed 
for 1.5 h with tic indicating the formation of the more polar vinyl thioacetate product. On 
completion, no work-up was required; rather the toluene was then removed under vacuum 
and the residue dried on a pump to give a yellow oil which was purified directly on a silica-gel 
column using 5% ethyl acetate in petroleum ether as eluent to give compound 14 as a 3:2 
mixture of ZlE stereoisomers (83% yield based on recovery of about 30% of compound 8). 
Evidence for a successful addition came firstly from the 1H NMR spectrum, which revealed a 
downfield shift for the alkynyl terminal proton of 8 into the vinyl region. Significantly, H-4 (see 
Figure 40 below) could be discerned as a pair of double triplets in the vinyl region at around 8 
= 6.5 ppm corresponding to the two geometrical isomers, with the larger vicinal coupling 













.. '" , m 
., 
'" 
Figure40: Exp l nded H NMR ..,~ctrum fc< ccmpou nd 14 
Results and Discussion 
T-
"'OIl 
Similarly, the other vinyl signal. H-5 could be readily discerned. also as a pair of double triplets 
but wi th a larger J value for the triplet part corresponding to the H-5/H-6 coupling. This vinyl 
vicina l combination also. importantly. coofi rmed the addition to be reg ioselective. wilh the 
sulphur adding to the terminus of lhe alkyne rather than the internal carbon, presumably on 
sleric grounds together with the greater stabili~ation afforded to the more subslLtuted vinyl 
radica l intermediate. Oiller diagnoslic signals included the two methyl acetyl singlets as well 
as the p-methoxybenzyl group signals Indeed the protoos of the S-allylthio group fo r each 
isomer could be readily discerned and are given in Table 3. However. the isomers couldn't be 
separated by chromatography. 
Table 3: DiElgnm;tlc peaks for ioontlflCation of compound 14 
Compound Chemical Shift Multiplicity I Coupling I Assignment 
i C~::::tt 
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14 Z S.84 dt 7.4,9.S H-S 
E S.80 dt 7.4, 1S.2 H-S 
14 Z 3.09 dd 1.0,7.4 H-6 
E 3.08 dd 1.1,7.4 H-6 
As expected, H-6 appeared as a pair of double doublets for the two isomers in view of their 
coupling relationships as well as their enantiotopicity. The 1H NMR spectrum also clearly 
revealed compound 14 to be obtained as a mixture of isomers by integration, with the Z-
isomer dominating the E- in a ratio of 3:2. The 13C NMR also confirmed the success of the 
addition by virtue of the appearance of a carbonyl group carbon observed at ~c 191.2 for the 
thioester. The mechanism of the radical addition presumably follows the classical radical 
pathway involving the three steps of initiation, propagation and termination as shown in 
Scheme 19. 
1) lritidian 
2b) P ro~lIdian 
]) T errrinlllion 
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Scheme 19.: Mechanism forthe radical addition reaction 
Thus, in the first step 1,1' -azobis( cyclohexanecarbonitrile) 9 undergoes thermal homolytic 
cleavage resulting in a-cyano radical 10. The thiolacetic acid (1.10 equiv) 11 in the reaction 
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2) Propagation to give 14 + 12 
The thiyl radical 12 then reacts with compound 8 to form a vinyl thioacetate radical 13. This 
then abstracts a hydrogen from the second thiolacetic acid to form compound 14 (83%) as a 
3:2 ratio of ZlE-isomer and radical 12 again, which enters a second cycle of propagation. 
3) Termination (dimerisation of 15) 
Two thiyl radicals 12 may dimerize to form disulphide diacetate 15, thus terminating the 
reaction. 
These findings agreed with the 3:2 ZlE-isomer ratio found in studies carried out by 
Kampmeier discussed in Chapter 2. 85 
In the next step, sulfenylating agent 18 was prepared by reacting potassium p-
toluenesulfonothiate 16 
dissolved in DMF with allyl bromide 17. The reaction proceeded at room temperature for 3 h 
before quenching with saturated aq. sodium bicarbonate and extracting with DCM. The 
extracts were dried with MgS04 and the solvent reduced under vacuum. The residue was then 
purified on a silica-gel column using 5% ethyl acetate in petroleum ether as eluent to give 
thiosulfonate 18 (92%) as shown in Scheme 20. The 1H NMR spectrum of 18, a known 
compound, revealed the required aromatic AS doublet pair integrating correctly against the 
upfield allyl signals. 
Scheme20 
DMF ~ 0 .. ~s 
II ..... S~ 
o 
18 
With the sulfenylating agent in hand, vinyl thioacetate 14 was deprotected by reacting it with 
KOH in methanol at -78°C to form the enethiolate anion 19. The low temperature was used to 
avoid side-reactions of the resultant enethiolate. It also reflects the weakness of the C-S bond 
of the thioacetyl group. The reaction was allowed to warm to -20°C before addition of 
thiosulfonate 18. TLC analysis showed a disappearance of enethiol and a new polar spot after 
stirring at room temperature for 3 h. This resulted in quenching the reaction with saturated aq. 
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chromatography using 5% ethyl acetate in petroleum ether to give compound 20 as a 2:3 
mixture of ZlE stereoisomers (84 % yield). A detailed mechanism is shown in Scheme 21. 
Meo~ KOH/-7S"e 7' I _ Meo~ 
~s~s--/ MeOH" ~ s~s 
II 19 
14 0 enethiolate 
13 
MeO~12 14 7 5 
I .611 S~~S_4~1 
10 9 S 
19 20 
Scheme21: Nucleophillic substitution of thioacetate 
Thiosulfonate 18 can be considered as a -CH2S-tosylate (Ts) grouping with the important 
difference compared to the more common -CH20Ts group that nucleophilic attack occurs at 
sulfur rather than at carbon. Thus 18 acts as a soft sulfenylating agent towards the 
enethiolate, which thiates on sulfur. The coupling gives a disulfide bond which is an interesting 
example of the soft-soft principle. The 1H NMR spectrum of 20 readily revealed a loss of the 
acetyl group of 14 and the introduction of a new allyl group. Once again, the allyl group of the 
vinyl disulphide moiety in 20 gave a pair of signals for each of H-6, H-7 and H-8 consistent 
again with the formation of two geometrical isomers. Also, the coupling relationships, eg dt for 
H-6 were similar to those of 14. However, regarding the EIZ ratio a change was observed. 
Instead of a 3:2 ZlE-isomer that was observed for compound 14, there was a change to a 2:3 
ZlE-isomer ratio. The reason for the shift towards the E-isomer suggests a thermodynamic 
equilibration of sorts that could occur due to protonation by MeOH of Z-enethiolate 19 to the 
enethiol 21 which undergoes tautomerism to form thioaldehyde 22. This is then followed by 
rotation of the C-1/C-2 single bond followed by tautomerism to form E-enethiol 23 which 
becomes deprotonated by methoxide to form E-enethiolate as shown in Scheme 22. 
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Compound 20 was also studied by 13C NMR, which returned 12 pairs of signals including four 
aromatic pairs for the benzene ring. C-6 was observed to be more downfield for both isomers 
compared to C-7. The reason may be because it is attached to the sulfur atom, which 
deshields it. 2D-techniques such as HSQC (H to C correlation) were used to assist with 
assignments given that the proton assignments were trustworthy. Similarly, the IR spectrum of 
20 confirmed the presence of a disulfide linkage at 450 cm-1. A high resolution mass 
spectrum (electrospray) confirmed the formation of compound 20 by showing a peak for 
disulfide cleavage of the molecular ion [M+ = C14H180S3+] to [M+ - C3H5S] at 225.0436 
(expected = 225.0408). 
In the final step, compound 20 was chemoselectively oxidized to a sulfoxide with 1 equivalent 
of m-CPBA (meta-chloroperbenzoic acid) 24 as the oxidizing agent. This reaction is 
chemoselective as m-CPBA preferentially oxidizes the sulfide S-atom over the sulfurs of the 
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Chapter 4 Results and Discussion 
The reaction was conducted at _78 0 in order to maximise selectivity. Tic at this temperature 
via quenching of an aliquot revealed that there was a presence of a new more polar spot with 
disappearance of compound 20 after 3 h. The reaction was then quenched with aqueous 
carbonate, the organic product extracted and following the normal isolation and 
chromatography (using 40% ethyl acetate in petroleum ether as eluent) gave 25 (2:3 ZlE 
83%). It was noted that the ZlE-isomer ratio of 25 did not change when compared to that of its 
sulfide precursor. The site of oxidation as the sulfide sulfur was indicated by downfield shifts 
of H-8 and H-10 (a- to the new sulfoxide grouping) relative to those in the sulfide precursor 
20. Thus, H-8 shifted from 3.19 ppm to 3.42 for the Z-isomer and 3.06 to 3.27 ppm for the E-
isomer. By comparison, those for H-3 a- to the disulfide allyl sulfur remained almost the same 
at 3.34 ppm. Further evidence was provided by the 13C NMR spectrum, which also revealed 
significant downfield shifts for C-8 and C-10. Table 4 summarises both Hand C chemical 
shifts for all of the positions a- to sulfurs (C-7 included) in both starting trisulfide 20 and 
sulfoxide product 25. 
Table 4: Diagnostic resonances for identification of compound 20 and 25 
Position Compounds 1H 0 Multiplicity; J 13C 0 
3 20 ZlE-3.34 m Z-42.1 
E-41.3 
25 ZlE-3.34 d,7.6 Z-42.1 
E-41.3 
6 20 Z-6.21 dt, 1.0,9.2 Z-132.8 
E-6.06 dt,1.0,14.7 E-132.8 
dt, 1.1,9.8 
Z-6.54 Z-138.2 
25 dt, 1.1, 15.0 
E-6.32 E-134.6 
7 20 Z-5.66 dt, 7.5, 9.2 Z-130.1 
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25 Z-5.80 m Z-118.4 
E-5.92 dt, 8.0, 15.0 E-117.3 
8 20 Z-3.19 dd, 1.0, 7.5 Z-32.7 
E-3.06 dd, 1.0, 7.3 E-29.4 
8a Z-3.40 ddd, 1.1,7.8,13.2 
25 Z-49.6 
8b Z-3.43 ddd, 1.1,7.8,13.2 
8a E-3.27 ddd, 1.1, 8.0, 13.2 
E-52.8 
8b E-3.51 ddd, 1.1, 8.0, 13.2 
10 20 Z-3.66 s Z-34.6 
E-3.62 s E-35.4 
Z-56.9 
25 ZlE-3.90 s 
E-56.3 
A further piece of supporting evidence showing a successful synthesis of compound 25 came 
from the observation of non-equivalence of the H-8 protons (observed as a pair of resonances 
for each geometrical isomer) as a result of diastereotopicity due to a chiral sulfoxide. The 
sulfoxide is chiral because it is asymmetric (one counts the lone pair) and configurationally 
stable at room temperature. Prior to oxidation, the H-8 protons were enantiotopic showing a 
single resonance for each geometrical isomer (as a doublet of doublets in each case). Upon 
oxidation, H-8 splits into two resonances for each stereoisomer, each one as a doublet of 
doublet of doublets as a result of geminal, vicinal and allylic coupling as shown in Table 8 and 
Figure 41. The H-10 signal was also expected to split into an AS doublet pair due to the 
diastereotopic nature of the sulfoxide, but only a singlet was observed for each isomer. The IR 
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~~~~~~~~~~~, IT"'" .-.,. .. -; '-'-'1 -f -.- , I I 
I '~ ,. ... .n •• •• ,. 
Figure 41: Expanded 'H NM R /oc cocnp rund 25 
Finally, a high resolution mass spectrum (Electrospray) gave definitive evidence 'I n support of 
2S The mass spectrum in Figure 42 shows a molecular ion of 3150551 glmol with virtually the 
same molecutar weight as that expected from the formula of 315.0547 glmol, thus proving the 
success of the oxidation step. 













Chapter 4 Results and Discussion 
The next set of targets chosen for synthesis were aimed at chemosensitization studies, an 
issue discussed in Chapter 2. These fell under the following structural type in which the 




~S ~S 's'" R R = allyl, propyl, methyl 
Figure43 
The reasoning behind these changes follow as: 
1) Ajoene has been shown to be a potent chemosensitizer in AML for cytarabine, with a mode 
of action believed to involve suppression of the anti-apoptotic protein bcl-2. Thus, a small 
library of ajoenes with small end-groups as shown in Figure 44 were chosen for study. 
o 
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Changing allyl to propyl at the sulfoxide end agreed with the UCT pilot study in which propyl 
was shown to have more or less the same activity as ajoene. 
2) Varying the allyl group at the disulfide end to another small group made sense for probing 












Chapter 4 Results and Discussion 
Retrosynthetically, all of the targets in Figure 44 above can be derived from the vinyl 
thioacetate 29 shown in Figure 45. 
9 7 1') 3 1 
~S~""Sij 
10 8 6 4 II 
29 0 
Figure 45 
Thus, for the synthesis of key intermediate 29, it was necessary to first synthesize compound 
28 from commercially available 1-propanethiol 26. The latter is very volatile with a boiling point 
of 65°C. The synthesis began with alkylating 1-propanethiol with propargyl bromide 27 as 





Scheme24: Alkylation of 1-Propanethiol with Propargyl bromide 
For the reaction, potassium hydroxide was dissolved in degassed methanol at 0° C under N2. 
1-Propanethiol 26 was then added dropwise followed by propargyl bromide 27 and the 
reaction allowed to proceed at room temperature for 2 h, after which time tic (hexane) 
indicated the formation of a non-polar spot that was UV active and presumed to be sulfide. 
The methanol solvent was then removed under vacuum on the rotoevaporator keeping the 
bath temperature at ambient temperature to minimize product loss and the residue was 
suspended in diethyl ether (40 ml), which was washed with water (3 x 10 ml). The ether 
extract was dried with MgS04 and the solvent removed taking precautions as before with bath 
temperature. The residue was purified by distillation at 150° C (atmospheric pressure) to give 
28 in 80% yield as an orange oil. Its structure was confirmed by the presence of an alkyne 
methine hydrogen triplet in the 1H NMR spectrum at 2.21 ppm due to coupling with the 
propargylic methylene (H-3) as with alkyne 8 previously. Other resonances were as expected 
and the 13C NMR spectrum returned the six expected resonances with ones at 80.1 (internal) 
and 70.7 ppm (external) for the triple bond. Furthermore, the IR spectrum gave a stretch at 
3290 for the terminal alkyne. 
The next step was a radical addition reaction on compound 28 using thiolacetic acid. The 
same procedure was adopted for the synthesis of 29 as for the conversion of alkyne 8 to p-
methoxybenzyl vinyl thioacetate 14. The desired vinyl thioacetate 29 was obtained after 2 hr 
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after column chromatography, Scheme 25. The ratio of the isomers was consistent with that 
found for the synthesis of compound 14 and that of Kampmeier,85 and the mechanism 
followed that was described in Scheme 19 before. 
1) Inrunon 
NU~· + -N~eat --_ .. o H~~ o ·A s 

















Scheme 25: M ern ani sm for the rad ical a ddition rea cti on 
Once again, evidence for a successful addition of thiolacetic acid came firstly from the 1H 
NMR spectrum, which revealed a new pair of thioacetyl methyl singlets as well as a downfield 
shift for the alkynyl terminal proton of 28 (H-1) into the vinyl region (H-4) as shown in Table 5. 
Table 5: 1H NMR data for the terminal hydrogens in 28 and 29 
Position Compounds 1H cS Multiplicity; J 13C cS 
1 28 2.21 t,2.6 70.7 
4 29 Z-6.65 dd, 1.3, 10.4 Z-119.1 
E-6.52 dt, 1.3, 15.7 E-118.8 
The 13e NMR spectrum of 29 also confirmed the success of the reaction with resonances due 
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ISOmer The mass spectrum also confim'lOd the success of the roadlon by showing both the 
parent I0I'l as "''ell as a fragment ion of M' • COCH3(147 0292 observed: 147.0302 eKpected) 
fitbng the structure of 29 shown below 
g 7 ~ 1 I 
~s~s« 
'0 ~ 6 • II 
o 
Chem.:::al Formula, C5H,.OS2 
Exact Mass 190 0486 
mfZ 190 05 (100.0%), 191 05 (10 5%), 19204 190%) 
ElernentaI Anal~5.ls C,5048, H 7410, 841 . $ . 3369 
""" _ • .to _ . ... 












• • • .. .. .. . 
• • 
Results and Discussion 
"" ... fl · 
"'0'''' 
With vinyl thioacetate 29 in hand, the various sulfenylating agents as S-ally1. S-propy1 and S-
Me could be prepared via nucleophilic substitution of the appropriate alkyl halide with 
potassium p-toluenesulfonothiate 16. 
" C 
" 30 R = ~ll yl X = Br 
31 R =prClJl yl 
X = Br 
32 R =Methyl 




33 R = all yl 
3( R =prop yl 
35 P =Methyl 
In each case. 16 was dissolved in DMF and a solution of the appropriate halide as ally1 
bromide 30. l-bromopropane 31 or methy1 iodide 32 added dropwise to the mixture. The 
reactions were then left stirring at room temperature for 3 h. Reactions could each be followed 











Chapter 4 Results and Discussion 
revealed similar resonances for the common propylSallylS- core for each stereoisomer, and 
data for the various protons and carbons are given in Tables 6 CH) and 11 C3C) respectively. 
11 9 7 5 3 1 
~S~S'S~ 
12 10 8 6 4 2 
11 9 7 5 3 1 
~s~s,~ 
12 10 8 6 ~ 2 ' 
9 7 5 3 1 
~S~S'S/ 
10 8 6 4 2 
40 41 42 
T bl 6 1H NMR D· a e lag f k f h t . f f d 40 41 d 42 nos Ie pea sore arae enza Ion 0 eompoun s , an 
Position Isomer 40 1H 41 1 H 0; Multiplicity; J 42 1 H 0; Multiplicity; 
0; Multiplicity; J J 
10/8 Z 2.48, t, 7.3 2.47, t, 7.4 2.47, t, 7.4 
E 2.45, t, 7.3 2.43, t, 7.4 2.46, t, 7.4 
8/6 Z 3.27, dd, 1.1,7.4 3.26, dd, 1.3, 7.4 3.26, dd, 1.0, 7.4 
8/6 E 3.19, dd, 1.2,7.7 3.17, dd, 1.3,7.7 3.20, dd, 1.0, 7.4 
7/5 Z 5.69, dt, 7.4, 9.7 5.66, dt, 7.4, 9.3 5.74, dt, 7.4, 9.3 
E 5.86, m 5.86, dt, 7.7, 14.8 5.90, dt, 7.4, 14.6 
6/4 Z 6.23, dt, 1.1, 9.7 6.23, dt, 1.3, 9.3 6.24, dt, 1.0, 9.3 
E 6.11, dt, 1.2, 14.6 6.11, dt, 1.3, 14.8 6.11, dt, 1.0, 14.6 
3/1 Z 3.37, m 2.70, t, 7.1 2.44, s 
E 3.35, m 2.68, t, 7.1 2.40, s 
The 13C NMR spectra for disulfides 40-42 showed a loss of the carbonyl group and the 
presence of new peaks for the allyl group of 40, the propyl group for 41 and the methyl group 
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Table 7: 13C NMR Diagnostic peaks for identification of compounds 40,41 and 42 
Position Isomer 40 41 42 
3 Z 42.1 41.1 -
E 41.3 40.4 
Chapter 4 Results and Discussion 
with DCM. The extracts were dried with MgS04 and the solvent reduced under vacuum. The 
residue in each case was then purified on a silica-gel column using 5% ethyl acetate in 
petroleum ether as eluent to give sulfenylating agents 33, 34 and 35 in 92, 92 and 96 % yield 
respectively as shown in Scheme 26. 1 H NMR spectroscopy of 33, 34 and 35 returned 
satisfactory and similar spectra regarding the aromatic protons. Simple integration of the 
aliphatic (34 / 35) or vinyl (33) to aromatic resonances appropriately gave the desired ratios. 
Similarly, 13C NMR returned four aromatic resonances for each and the aromatic methyl group 
highfield in each case. The other signals tallied appropriately. 
Sulfenylation of 29 with 33, 34 and 35 was carried out using the same set of experimental 
conditions as for reaction of thioacetate 14 to give compound 20 involving S-acetate cleavage 






:-s? R rrY -'S-
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40 R = allyl 
41 R = propyl 
42 R = methyl 
Scheme 27: Nu cleoph illic su bst~ution of thio acetate 
Reactions took 2, 4 and 3 h respectively after addition of the sulfenylating agents to complete 
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Each pair of geometric isomers (43, 44 and 45) will be discussed separately highlighting 
important features that prove that oxidation did occur and that the site of oxidation was at the 
sulfur of the sulfide not the sulfur of the disulfide group. For compound 43, the site of oxidation 
at the sulfide sulfur was indicated by downfield shifts of H-1 a and H-8 (a- to the new sulfoxide 
grouping relative to those in the sulfide precursor 40). Thus, H-8 shifted from 3.27 ppm to 
3.56/3.63 for the Z-isomer and 3.19 to 3.43/3.51 ppm for the E-isomer. By comparison, those 
for H-3 a- to one of the disulfide sulfurs remained almost the same at 3.37 ppm and 3.35, 
Table 8. Secondly, the non-equivalence of the H-8 protons upon oxidation (shown by a split of 
H-8 hydrogens- a pair of doublet of doublets for each isomer) due to diastereotopicity of the 
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11 7. 5 3 1 
~S~S'S~ 
12 10 9 8 6 4 2 
40 
o 
11 II 5 3 1 ~S~S,~ 
12 10 9 8 6 S 2 
4 
43 
a e T bl 8 1H NMR C ompanson 0 lagnos Ie pea s 0 an f d· r k f 40 d 43 
Position Isomer 40 1 H 8; Multiplicity; J Hz 431H 8; Multiplicity; J Hz 
10 Z 2.48, t, 7.3 2.61/2.67, dt, 8.2, 13.7-ZAB 
E 2.45, t, 7.3 2.61, m 
8 Z 3.27, dd, 1.1, 7.4 3.56/3.63, dd, 8.1, 13.2 ZAB 
E 3.19, dd, 1.2,7.7 3.43,13.51, dd, 7.9, 13.2 EAB 
8 
7 Z 5.69, dt, 7.4, 9.7 5.76, dt, 8.1, 9.2 
E 5.86, m 5.91, dt, 7.9, 14.6 
6 Z 6.23, dt, 1.1,9.7 6.54, d, 9.2 
E 6.11, dt, 1.2, 14.6 6.34, d, 14.6 
3 Z 3.37, m 3.37, m 
E 3.35, m 3.33, m 
The 1H NMR of compound 44 also showed a similar pattern as compound 43. The hydrogens 
a-to the sulfoxide both shifted downfield relative to the trisulfide precursor 41 as shown in 
Table 9. The influence of the chiral sulfur was observed by the splitting of H-8 indeed 
confirming the success of the chemoselective oxidation step. Prior to oxidation H-8 was 
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Table 9: 1H Comparison of diagnostic peaks for 41 and 44 
Position Isomer 41 1 H 0; Multiplicity; J 44 1 H 0; Multiplicity; J 
10 Z 2.47, t, 7.4 2.65, m 
E 2.43, t, 7.4 2.65, m 
8 Z 3.26, dd, 1.3, 7.4 3.52/3.63, dd, 7.46, 13.4 ZAB 
E 3.17, dd, 1.3,7.7 3.45/3.52, dd, 7.8, 13.0 EAB 
8 
7 Z 5.66, dt, 7.4, 9.3 5.75, dt, 7.6, 9.5 
E 5.86, dt, 7.7, 14.8 5.93, dt, 7.8, 15.0 
6 Z 6.23, dt, 1.3, 9.3 6.56, d, 9.5 
E 6.11, dt, 1.3, 14.8 6.37, d, 15.0 
3 Z 2.70, t, 7.1 2.65, m 
E 2.68, t, 7.1 2.65, m 
The 1H NMR of compound 45 also confirmed the success of the chemoselective oxidation of 
compound 42. H-6 shifted (a- to the new sulfoxide grouping) from 3.26 ppm to 3.50 ppm. A 
further piece of supporting evidence came from the observation of non-equivalence of the H-6 
protons (observed as a pair of double doublets for each of the geometrical isomers), as a 
result of diastereotopicity due to a chiral sulfoxide as with 43 and 44. Prior to oxidation, H-6 
was enantiotopic showing a doublet of doublets. Upon oxidation H-6 splits into two doublets of 
doublets as H-6a and H-6b as a result of geminal and vicinal couplings. This evidence also 
eliminated the possibility of oxidation at S-3/S-2. In such a case, oxidation of the disulfide to 
an allicin-like thiosulfinate would have made the molecule very labile. Also, the IR spectra 
confirmed the presence of an intact S-S grouping via a stretch at around 460 cm-1. The 
resonances for compound 45 are tabulated in Table 10 in order to compare them with the 
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9 5. 3 1 
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Table omparison 0 f d· k f 42 d 45 lagnostlc pea s or an 
Position Isomer 42 1H 0; Multiplicity; J 45 1 H 0; Multiplicity; J 
8 Z 2.47, t, 7.4 2.58, m 
E 2.46, t, 7.4 2.65, m 
8 
6 Z 3.26, dd, 1.0, 7.4 3.50/3.59, dd, 7.7,13.2 ZAB 
E 3.20, dd, 1.0, 7.4 3.44, m 
5 Z 5.74, dt, 7.4, 9.3 5.77, dt, 7.7, 9.3 
E 5.90, dt, 7.4, 14.6 5.90, dt, 7.4, 14.8 
4 Z 6.24, dt, 1.0, 9.3 6.55, d, 9.3 
E 6.11, dt, 1.0, 14.6 6.33, d, 14.7 
1 Z 2.44, s 2.41, s 
E 2.40, s 2.36, s 
Further evidence was provided by the 13C NMR spectra, which also revealed significant 
downfield shifts for C-8 and C-10 (for compounds 43 and 44) or C-6 and C8 for compound 45 
(Table 11). 
Table 11: 13C Diagnostic peaks for identification of compound 43, 44 and 45 and their precursors. 
Position Isomer 40, 43 41, 44 42, 45 
8/6 Z 29.5 , 50.9 29.4, 50.9 29.4, 50.8 
E 33.5 , 54.7 33.5, 54.5 33.5, 54.6 
10/8 Z 33.4 , 53.5 33.1, 53.4 33.3, 53.4 
E 33.1 , 53.0 32.9, 53.1 33.1 54.6 
The IR spectra of 43, 44 and 45 also showed a peak due to the sulfoxide 1300 cm-1. Mass 
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mass-spectrum for compound 44 showed a dominant peak at 146.0211 consistent with 
el imination of PrSOH (propylsulfenic acid), [M' - PrSOH; expected mass" 146.0224]. 
Chem >;:al Formula' CSH10S, 
Exact Mass. t46 0224 
mJz 146.02 (100.0'%), 14802 (9.0"10) , 14703 (6.6%). 
147.02 (1 .6%1 
Elemertal AnalySIS C, 49 27; H, 6 89; S, 43 84 
. , ; 
, ........ " ...... "" 
• 
• • 
Goo.m .. ,·m ", . 
In conclusion, the UCT reaction sequence was successful in the synthesis of a small libra!)' of 
ajoene derivatives. It has Deen shown that changes can De either in one allyl group or both 
groups. The vinyl sulfide pharmacophore was not changed for all the derivatives The overall 
Yield of the four-step sequence for each case was in the range 25-47 %. After a successful 
synthesis of these derivatives. inclusion of the synthesized ajoene derivatives into cyclodextrin 
was attempted (Chapter 5). This was then followed by bIOlogical evaluation of the atoone 
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5.1 Cyclodextrins 
5.1 Natural Origins 
The enzymatic degradation of starch results in the production of glucose, maltose, maltotriose 
and other saccharides, that is a long series of linear or branched-chain malto-oligomers 
known as dextrins.9o Dextrins are heterogeneous, amorphous and hygroscopic substances 
which are produced in large quantities in food such as bread or beer or as textile paper.91 The 
degradation of such starch is a hydrolytic process and the primary product from this hydrolysis 
of the glycosidic linkage reacts with water. The enzyme responsible for degradation of the 
starch is glucosyltransferase enzyme (cGT which is produced by micro-organisms Bacillus 
macerans, Klebsiella oxytoca), and in this enzymatic process the primary product of chain 
splitting undergoes an intramolecular reaction without the participitation of a water 
molecule.9o,91 Since these enzymes are not specific the outcome is the formation of variable 0-
1 ,4-linked cyclic products called cyclodextins. 
5.2 Historical origins 
In 1891 Villiers reported the formation of some unidentified crystalline substances during the 
fermentation of starch in the presence of Bacillus amylobacter. He assumed the substance to 
be cellulose and named it cellulosine.92 Fifteen years later Franz Schardinger, an Austrian 
microbiologist, isolated a microorganism named Bacillus Macerans which produced two 
distinct reproducible crystalline substances when cultivated on starch-containing medium.93 
He then named the dextrins 0- and l3-dextrins. These names were proposed due to the fact 
that degradation of these substances was similar to degradation of starch products. It was in 
1936 that Freudenberg and co-workers determined the structure of these dextrins.94-96 
Freudenberg postulated the crystalline structure to be formed of maltose units joined by 0-1,4-
glycosidic linkages. In 1950 two groups led by French and Cramer did further analysis on 
these dextrins. French discovered that there are even larger CDs, while Cramer focused on 
inclusion work. In 1953 Freudenberg, Cramer and Plieninger obtained a patent on CDs 
describing application and toxicity in drug formulation. 94 In 1981 the first international 
symposium was organised where scientists would have the opportunity to summarize the 
most recent results. Since then symposia have been held every second year and 
presentations have increased in both quantity and quality.97-101 Today CDs are relatively 
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5.3 Structural features of cyclodextrins 
The three major native cyclodextrins are a-, [3- and y-cyclodextrins as shown in Figure 48 
below. These are macrocyclic oligosaccharides containing 6, 7 and 8 a-1 A-linked D-
glucopyranose rings respectively. The shape resembles that of a hollow truncated cone. As a 
consequence of the 4C1 conformation, the narrow rim is lined with primary hydroxyl groups 
and the wider rim with twice as many secondary hydroxyl groupS.93 
Figure 48 Native cyclodextrin 593 
The cavity is lined with hydrogen atoms and glycosidic oxygen atoms. The nonbonding 
glycosidic oxygen electron pair is directed towards the cavity; this arrangement increases 
electron density in the cavity resulting in its Lewis base character.93 Therefore the internal 
cavity is hydrophobic relative to the hydrophilic exterior portion. 
5.4 Torsion angles and Macrocyclic geometry 
French noted a correlation between the 04(n) ... 04(n-1) distance and certain endocyclic 
torsion angles in several pyranoses. 102 Figure 49 shows a three dimensional structure of a [3-
CD. The conformation is stabilized by C-H ... O H-bonds. The average planes of the glucose 
molecules are not perpendicular to the 0(4) plane but incline mostly with the 0(6) side 
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The 04(n) ' 04(n-1) distances are almost the same in all CDs. In line with these 
observations the distribution of 04(n) ' " 04(n-1) ... '04(n-2) angles were 10und to be 120" for 
o-CDs, 1280 for i3-CDs and 135' for V-CDs In prinaple there are three orientations of the C6-
06 bonds in gtucose units, corresponding to dihedrat angles 05-C5-C6-06 that are (+)-
gauche, (- r-gauche and trans-orientation, yet on ty the first two have been observed thus far as 
shown in Figure 49. The trans-orientation cou ld also be destabilised by the gauche-effect 
operating in the O-C-C-O systems.'"' 
5.5 Hydrogen bonding 
Structural rigidity of the cyclodextrin macrocycle is primarily due to the presence of a ring of 
hydrogen bonds. It was found that the intramolecular hydrogen bonding IS formed between a 
C-2-0H group of one glucopyranose unit and a C-3-0H group of the adjacent glucopyranose 
unit." i3-CD 10rms a complete H-bond belt, whereas a-CD forms an incomplete belt 
Therefore, o-CD has four intramolecutar hydrogen bonds instead of six Since i3-CD fo rms a 
complete belt, this intramolecular H-bonding explains the observation that i3-CD has the 
lowest water solubility of al l the CDs The average 0 0 distance for hydrogen bonding 
between cyclodextrins is not constant but decreases from one CD to the next. a-CD (2 gSA), 
i3·CD (2.S8 A) and V-CD (2.82 A) . This decrease in distances indicates that H·bonds become 
Increasingly stronger as the number of glucopyranose rings increases. The 02(n) " '''03(n-1) 
hydrogen bonds are the major component of H-bonding, of which the minor component 
donates to the oxygen of the glycosidic atom . '0' This character contributes to the ngidity as it 
strengthens the 02(n) ·,, ·03(n-1) hydrogen bonding irlteractions. The weak irltramolecular 
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interactions. Sometimes these interactions are mediated by water molecules as in, for 
example, 06 "" W "" 05, where 06 and 05 belong to the same gtucose unit. 
5.6 Cyclodextrin derivatives 
As previously shown. every glucopyranose unit has three free hydroxyl groups which differ 
both in their functions and reactivity. This is determined by the pH, temperature and solvent, 
In f3-CD there are 21 hydroxyl groups which can be modified by a large variety of substituting 
groups such as alkyl, hydroxyalkyl, carboxyalkyl and amino as shown in Figure 50 below, 
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FiUlIre!iO Skeleton of a c y clude~trin deri Yative 
The primary purpose of these modifications is to improve the solubility of CD derivatives, to 
improve the fitting of a guest molecule, to attach specific (catalytic) groups to the binding site 
(e.g en.ryme modelling) and to form insoluble, immobilised CD-containing structures 
polymers e,g for chromatographic purposes, The most important (3-CD derivative is the 
heterogeneous, amorphous and h>ghly water SOluble (3-CD derivative This can be methylated 
or propyla ted to fo rm methylated f3-CD or 2-hydroxypropylated 13- CDs. Methylated (3-CDs are 
more hydrophobic than f3-CD itself Therefore they form more stable soluble complexes with 
cholesterol. Some of these CDs are heptakis (2,6-di-O-methyl)-f3-cyclodextrin (DIMEB), 
heptakis(2, 3 ,6-tri-O-methyl}-(3-cydodextrin (TR I MEB) and randomly methylated-(3-cyclodextrin 
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5.7 Crystal packing arrangements of Cyclodextrins and their inclusion 
complexes 
For crystallization of an ir>eluSion complex of a CD one has to add the guest molecule in order 
to fOfm a com~ex. In crystals, the molecules are arranged in a lattice in either of two modes, 
described as cage and channel structure accOfding to the overall appearance of the formed 
cavities. 
5.7.1 Channel-type structures 
In this motif, cyclodextrins are stacked on top of each other like coins in a roll and linearly 
aligned cavities form 'infinite channels. in which the guest molecules are embedded, as shown 
in Figure 51 10' 
Fi'l",e51 Channel-t ~ pe packinq 
The stacks are stabilized by hydrogen bonds between the secorillary 02-H/03-H arld the 06-
H Sides producing head-to-tail patterns or between 02-HI03-H arill 02-H/03-H on one side 
and between 06-H arld 06-H on the other side leading to a head-to-head arrangement. 8\ 13-
CD can be arranged in such a way that the molecules stack to form dimers. hydrogen IxJrilled 
at their 02-H/03-H sides. They form basket-like units in which the guest molecules are 
accommodated. The dimers are therJ stacked and interact with their 06-H sites to fOfm the 
charlnel structure 
5.7.2 Cage-type structures 
ThiS type of structure may exist as herringbone or brick motifs The herrirlgbone motif is 
packed in such a way that Orle CD molecule is blocked off on both sides by adjacent COs 
thereby leading to isolated cavities in which guest molecules are not in contact with each 
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, . 
F iqlll e 52 Two Caq e-typ e p acklnq arranq sments, <l. he rn nq bone motif b. brick ma tif lOl 
The brick' motif is analogous to the stacking of bricks in a wall. The CD molecules are 
arranged in layers and adjacent layers are laterally displaced so Ihat the cavity of each CD is 
closed on both sides by molecules in adjacent layers, as shown in Fig 52b,' " This motif can 
also assume variations, in which dimer 'baskets' are stabilized intermolecularly by hydrogen 
bonding between the 02-H/03-H sides and arranged in layers which are displaced laterally. 
5.8 Applications of Cyclodextrins 
Cydodextrins have been used in various industries for a wide range of purposes such as 
incorporalion in items ranging from chewing gums to detergents 'CJ.1,,,,,, They are also used in 
everyday prcducts such as shampoo and toothpaste,' ''" The ability of CDs to incorporate 
guests WIthin their cavity has been advantageous in many applications ",", They are used to 
conlro l solubility, mask agents, provide stabilization artd also solubilise hydrophobic 
compounds in aqueous media.,""lot For example, hespiridin is a compound responsible for 
both the visible cloudiness and bitter taste in canned oranges Yasumatsuk and co-workers 
discovered that the addition of a CD reduced both the cloudiness and bitter taste of 
hespiridin' oo An increase in the solubility of a drug generally increases Its bioava,lability. 
Itraconazole. an anti-fungal drug, is ineffective when administered alone. However the 
complex of itraconazole With hydroxypropyl-~-CD shows increased bioavailabilily due to its 
increased solubility' ''' Cyclodexlrins have also been used to mask unpleasant flavours/smell 
in deodorants and lotions as well as menstrual prooucts, diapers, tiSSueS and paper 
lowe l s,~,110 Reduction of volatility of compounds through complexation has been used In 
control led-re leased applications. When a delergent containing a perfume/CD complex IS 
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preferentially, replace the perfume and release the fragrance. CDs can also incorporate 
pesticide molecules in order to improve their wettability.107 
5.9 Inclusion complexation 
Inclusion complexation is the largest area of interest in cyclodextrin research. The majority of 
cyclodextrin complexation studies are performed in aqueous environments in order to prevent 
competition with a guest molecule in non-aqueous solution. Szejtli and Connors proved that 
the complexing strength of a cyclodextrin is a result of hydrophobic-hydrophobic interactions 
between the guest and the host.107,111,112 Cramer and co-workers were the first to employ CDs 
as catalysts in synthetic reactions. They explained the mechanism whereby a cyclodextrin 
acts as an enzymatic model.94 Since then there has been a tremendous interest in 
cyclodextrins as biological catalysts, especially as dual phase catalysts and they are also 
used in the hydrolysis of phosphate esters.97-104 Phosphate esters are the most toxic esters 
and there has been tremendous need to use cyclodextrins for their hydrolysis. The paper by 
Trotta and coworkers reports an investigation of P-O hydrolysis under green chemistry 
conditions.116 This was investigated using p-nitrophenyldiphenyphosphate (PNPDPP) as a 
substrate and a membrane reactor with ~-CD derivatives as the host. 117 The hydrolysis of 
PNPDPP to PNP (p-nitrophenol) was then investigated. This was made possible by creating 
two environmental conditions, a homogeneous and a heterogenous environment as described 
in the paper. For the homogeneous environment, p-nitrophenol (PNP) concentration was 
recorded spectrophotometrically at 401 nm using a 1-cm quartz cell at room temperature. 
Samples of both the heterogeneous and homogeneous reactions were taken and measured 
to ascertain PNP concentration. In the homogeneous reaction, it was shown that separation 
of the product from the catalyst was difficult. This problem has recently been solved by 
immobilizing cyclodextrins on suitable cross-linked polymers. 118 Heterogeneous-mixture 
conditions proved that it is not possible to separate the product from the catalyst when using 
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Figure 53: Showing hyd ro lysis of PNPD PP to PNP with a variety of ~·CD d eriv ativ es 
Figure 53 shows that the hydrolysis of P-O in PNPDPP to PNP is dependent on the nature of 
the [3-CD derivative used and it was also observed that very little hydrolysis occurred in a 
membrane without cyclodextrin. Inclusion complexation has also been employed to increase 
guest stability. One example, from our laboratory, is the stabilisation of a derivative of allicin 
via its inclusion in permethylated [3-CD (TRIMEB). Whereas the derivative is chemically 
unstable at room temperature, when it is included in the TRIMEB molecule it is stable at 
temperatures higher than 50°C. 
5.10 Complex characterization 
Cyclodextrins and cyclodextrin inclusion complex have been characterized by different 
techniques including NMR analysis, calorimetry and TGA, X-ray diffraction methods, electric 
field pulse techniques, volumetric techniques, electron microscopy, circular dichroism and 
electron resonance (ESR and EPR).100 From NMR spectra it is possible to distinguish protons 
located on either the exterior or the interior of the truncated cone and those of the guest. 120 
Inclusion complex stoichiometries are elucidated either by TGA or NMR analysis. For 
crystalline CD hosts and their inclusion complexes, powder and single X-ray diffraction 
techniques yield detailed information concerning the host-guest interaction. Complex stability 
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6.1 Attempted preparation of inclusion complexes of an ajoene mimic with 13-
cyclodextrin, y-cyclodextrin and TRIMEB; physicochemical 
characterization of the TRIMEB complex 
6.1.1 Host compounds 
The host compounds ~-CD, V-CD and TRIMEB were obtained from Cyclolab [Budapest, 
Hungary] and were used as received. 
6.1.2 Guest compound 
A mixture of ZlE 1 0-(methoxyphenyl)-9-oxo-4,5,9-trithiadeca-1 ,6-diene stereoisomers was 
synthesized in Prof Roger Hunter's laboratory using the synthetic procedure developed at the 
University of Cape Town as described in detail in chapter 2. 
6.1.3 Complex preparation and crystal growth 
Inclusion complexes of 10-(4-methoxyphenyl)-9-oxo-4,5,9-trithiadeca-1 ,6-diene with TRIMEB, 
~-CD and V-CD were prepared by the co-precipitation method. For the co-precipitation 
method, a known quantity of TRIMEB (136.40 mg, 0.095 mmol) was dissolved in 2 cm3 
distilled water. An equimolar amount of guest (30.00 mg, 0.095 mmol) was then added and 
the solution was left stirring at O°C for 6 h. The cold solution was then filtered into a clean vial 
using a 0.25 j..Im Teflon Millex-LCR filter in order to remove dust and debris, thereby reducing 
nucleation sites. The vial was closed with a lid, two small holes were made on the lid, and the 
cold solution was placed in the oven at 50°C and left there overnight. The following day, 
colourless prismatic crystals of the TRIMEB inclusion complex were present at the top and 
bottom of the vial. The prismatic shape of the crystals was the same throughout. ~-CD (123.8 
mg, 0.095 mmol) was dissolved in 2 cm 3 distilled water while V-CD (134.1 mg, 0.095 mmol) 
was dissolved in 2 cm3 distilled water at 65°C. Once all the CD had dissolved, an equimolar 
amount of the guest (30.00 mg, 0.095 mmol) was added to the solution followed by vigorous 
stirring for 4 h. The solution was filtered (0.45 j..Im) and left at room temperature to induce 
crystallization. However, no evidence of crystalline inclusion complex formation with either of 
the parent cyclodextrins was found using the above conditions. 
6.2. Complex characterization methods 
6.2.1 Powder X-ray diffraction 
A representative sample of crystals of the TRIMEB inclusion complex from the top and bottom 
of the vial was removed from the hot mother liquor and dried. This sample was then ground at 
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known complexes. This was packed in an aluminium holder and a powder X-ray diffraction 
pattern was recorded using a Huber Imaging plate Guinier camera 670 with Nickel-filtered 
CuKa1 radiation (A = 1.5405981 A) produced at 40 kV and 20 mA by a Philips PW1120/00 
generator fitted with a Huber long fine-focus tube PW 2273/20 and a Huber Guinier 
Monochromator Series 611/15. The pattern was recorded at steps of 0.005° over the 28 
range of 5-40°. 
6.2.2 Single crystal X-ray diffraction 
A single crystal of the TRIMEB inclusion complex of size 0.15 x 0.16 x 0.26 mm was coated 
with paratone oil (Exxon, USA) and mounted on a Nonius Kappa CCO diffractometer for 
intensity data-collection with MoKa X-rays (A = 0.71073 A). The crystal was cooled to 113 ± 2 
K in a stream of nitrogen vapour to enhance diffraction quality and intensity data were 
collected using <1>- and w-scans of 1.0° and 1.2 °C (program COLLECT).113 Unit cell 
refinement and data reduction were performed with OENZO-SMN 121 and the structure was 
solved by isomorphous replacement using the rigid skeleton of the host molecule of the 
TRIMEB·(Z)-ajoene complex as a trial model. 114 All remaining non-H atoms of the host and 
guest were located in successive difference electron density maps. Guest electron density 
peaks could be interpreted as representing the E-isomer only, with the sulfonyl group 
indicating only one enantiomer. All the non-hydrogen atoms of the host were refined 
anisotropically while the guest atoms were treated isotropically. H atoms were added in 
idealized positions in a riding model with isotropic thermal parameters equal to 1.2-1.3 times 
those of their parent atoms. Full-matrix least-squares refinement on F2 was performed using 
the programme SHELXL-97115 with weights of the form w = [02 (Fo2) + (ap)2 + bpr1 and P= 
[max(Fo2 , 0) + 2Fo2]/3. 
6.2.3 Differential Scanning Calorimetry (DSC) 
OSC was used to measure the melting point of the TRIMEB complex. This was performed 
using a Perkin Elmer PC7 system under Nrpurge (flow rate 30 cm3/min). The instrument was 
calibrated with high purity indium and zinc standards. A 4.03 mg sample of the inclusion 
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6.2.4 Hot Stage Microscopy (HSM) 
HSM was used as a visual tool to determine thermal events of the sample during the heating 
process. Events such as colour or opacity changes in crystals which go undetected by the 
DSC method are easily detected with HSM. The crystals of the inclusion compound were 
heated on a Linkam THMS600 hot stage mounted on a Nikon SMZ-10 stereoscopic 
microscope, on which a Nikon FX-35 camera was mounted for simultaneous photography. 
The temperature was controlled by a Linkam TP92 temperature controller and was raised 
manually at a linear rate. The images were captured using a soft Imaging System camera and 
analysed using analySIS® Image software (Soft Imaging System program analysis).122 
6.2.5 Nuclear Magnetic Resonance (NMR) Spectroscopy 
To obtain a reliable estimate of the host-guest ratio of the TRIMEB inclusion complex, it was 
decided to use 1H NMR spectroscopy of a sample prepared by dissolving crystals of the 
inclusion compound in an appropriate solvent. Thus, a sample of crystals was removed from 
the mother liquor and dried on a filter paper to remove excess solution. It was also necessary 
to wash the crystals to remove any residual guest material (in the form of an oil) that might not 
have included in the cyclodextrin host. Cold solvents with different polarities were used. These 
included acetonitrile, water, hexane and acetone. Hexane was the best solvent for washing as 
it did not dissolve the complex. The crystals were weighed before washing and reweighed 
after washing and there was a noticeable mass loss due to the surface guest being removed. 
The washed product (5.00 mg) was dried on a filter paper and dissolved in CDCI3 and this 
solution was then submitted for 1H NMR analysis. TRIMEB (5.00 mg) and the guest (10.0 mg) 
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Chapter 7: Results and discussion 
This chapter discusses visual and analytical methods used to confirm complex formation. These 
methods included Powder X-ray diffraction (PXRD), Hot Stage Microscopy (HSM), Differential 
scanning calorimetry (DSC), and Single Crystal X-ray diffraction methods. The results from the 
analysis revealed that inclusion of the guest was only possible with TRIMEB. 
7.1 Powder X-ray Diffraction Studies 
Complex Preparation 
Co-precipitation method: I3-CD was dissolved in 2 cm 3 distilled water and V-CD was also 
dissolved in 2 cm 3 distilled water at 65°C. Once all the CD had dissolved, an equimolar amount 
of the guest as a mixture of E/Z-isomer was added to the solution followed by vigorous stirring 
for 6 h at 65°C. Table 12 shows the amounts of guest and host used in the co-precipitation 
method. The solution was filtered (0.45 !-1m) and left at room temperature to induce 
crystallisation. However, the permethylated host TRIMEB was dissolved in 2 cm3 distilled water 
at 0° C, and an equimolar amount of the guest as a mixture of E/Z-isomer was added and left 
stirring vigorously at 0° C for 6 h. The solution was then filtered (0.45 !-1m) and incubated at 50° 
C to induce crystallization. 
Table 12· Molar quantities for complex preparation 
Guest (mg, mmol) I3-CD (mg, mmol) V-CD (mg, mmol) TRIMEB (mg, mmol) 
10-( 4-Methoxyphenyl)-9-oxo-4,5,9- 123.8, 0.095 134.1, 0.095 136.4, 0.095 
trithiadeca1 ,6-diene (30.0, 0.095) 
Suitable crystals of an inclusion complex were obtained only with the host TRIMEB. A batch of 
crystals was scooped out of the crystallization vial, dried and ground for 1 h for comparison of its 
PXRD trace with those of known complexes The PXRD pattern of the crystalline product was 
compared with PXRD patterns of the crystalline host (TRIMEB, existing in three distinct crystal 
forms) and those of the isostructural reference patterns for known TRIMEB complexes. This 
revealed that the product was not the host compound. However, an acceptable match of the 
PXRD trace with that of a known isostructural TRIMEB complex series (BD 3) was obtained, as 
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Figure~ : Exp",mental PXRD t,"ce for the PrOOuG( of co-proopilatk>n of TR IMEB 000 th~ gu~'t (top) and a 
c~ed r"'~r~"'e p~ttern for a known I,,,,,uucl oral wmplex ""'"" (batt"""l . 
This agreement reveals the isostro.x;tural retationship between the complex and those of series 
803. Isostructurallty refers to two or more crystalline phases sharing the same three-
dimenSional packing arrays. with similar unit cell dimensions and internal motecutar 
arrangements' ''' As observed from the PXRD traces. the experimental and reference peak 
positions and intensities are not identical. This is due to the fact that the reference trace is the 
average pattern for a series of complexes with different crystal water contents, types of guest 
present size and orientation of the guest molecules as well as the temperatures at which the 
respective data were collected, However, using this technique of crystal characterization the 
level of agreement. especially as regards peak angular positions are concerned, is good, The 
predicted space group and unit cell dimensions. based on the PXRD match that indicates 
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Tabl. 13: Estimated "':lit cell data lor 1he TRIMEB comple ,ba,sed 00 isostrucnxal an 
Space Group Isostruc. Class a (A) b ,A, c (A) a (0) ~ (0) y (0) 
P2,2,2. BD3 
"----__ ----L 
.0 27,9 00.0 000 000 14.8 21 
1.2'H NMR Analysis 
Representative complex crystals were scooped from the vial and washed with cold acetonitrile 
before dissolving them in chloroform and submitting Ihem for H NMR analysis. TRIMEB was 
also dissolved in chloroform and submitted for 'H NMR analysis. All the diagnostic peaks for 








Fiq",e55 'H NMR spectrum forTRIMEB 
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0.0 
A window-like area was observed between 5.0 ppm and 7.2 ppm which was not found in the 
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Fiy", .. 56 'H NMR spectrum of the romp ... 














Both g_Sl and host peaks _II observed in Figure 56 confirming thaI l he g ... esl was 
sueeessl ... 11y mcll.ldDd in TRIMER The 'H NMR was consistent WIth results 'rom the $yn1hosls 
thal showed a 2,3 ZlE-ISomer ratio, a~houGh the single c:rr.;ta l lhal was s.eleaed for the X-ray 
dlffraClion study was 1M Z~sOl1ltlr, 
7,3 HSM Analysis 
HSM IS ... sed as a V1s ... al tool to sludy Ihe morpholOgy and physical manges of a crystal as it is 
heated over a given lemperatulU range Changes detected can be related 10 physloocoemit:al 
evenlS suen as guest release (and/or dehydrat;oo in the case of hydrated complexes), melling, 
and comple~ decompoSition Cry.,tats were dr1ed, immersed In silicone 001 and healed at a 
sc::al'lnll'lg rale cI to K min-' The clear , pflsmahc cry~at did nOl show any morphotogical 
chang.es belWl!en mom lempelalure and 150 · C, In the range 154,5-1 55, I ·C the CfY"at melted 
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, 
25 ·C 100 "C 150 ' C 155 "C 
The HSM findings are in agreement with the conclusions from the DSC analysis (below) thai the 
crystal is unsolvated and that the melting point is about 154"C 
7.4 DSC Analysis 
For DSC analysis. the sample was crushed, the excess water being removed by drying the 







Figur. 5~: DSC ',"ce of th e TRIMEcB .., olu, ,,," comp", 
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From the DSC trace, the only endotherm observed occurred at 1554 ' C and was attributed to 
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7.5 
Complex Formula 
Crystal Structure Analysis 
7.5.1 Space Group Determination, Structure Solution and Refinement 
Preliminary unit cell parameters and the space group were obtained form intensity data 
measured on a Nonius Kappa CCO diffractometer. Identification of the Laue symmetry of the 
reciprocal lattice as mmm indicated the orthorhombic system while the systematically absent 
reflections revealed that the space group of the complex is P212121, as predicted from the PXRO 
trace (Section 7.1). The structure of the complex was solved by isomorphous replacement using 
published co-ordinates of the host molecule in the known TRIMEB'(Z)-ajoene complex. 99 
Refinement of the host molecule followed and the atoms of the guest were located in 
subsequent difference Fourier syntheses. Anisotropic thermal parameters were employed for 
the host atoms. Bond length constraints were applied to the guest molecule to maintain 
reasonable geometry and the guest atoms were refined with a global isotropic thermal 
parameter. The structural solution confirmed that the crystal is unsolvated, as inferred from the 
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7.5.2.2 Mode of Guest Inclusion 
A perspective view of the complex structure is shown in Figure 59. with the host in ball-and-stick 
mode and the guest in space-filling representation. The guest molecule adopts a hairpin 
conformation with the sulfoxide moiety located near the cavity 'roof and the methoxyphenyl and 
allyl residues directed towards the secondary rim of the host molecule. The guest molecule, w~h 
H atoms removed. is drawn separa tely on the right in the Figure below, It IS evident that in the 
crystal selected, the ',ndusion complex comprises one host molecule and one guest molecule, 
Ihe latter being the R-enantiomer of the two enantiomers of the Z-isomer 
F'gUf. 59: The 1:1 in cl """,n com pl ex (Iefl) and an e nla r~ ed ","w of the \lU""I1 ""' " cule (ro:!'l ) H atoms h;l.c bern 
o m, led for c lar;ly 
There is no significant molecular disorder in the complex (a somewhat unusual feature for an 
indusion complex of th is type) and flO evidence was fOlJnd for indlJdmJ water molecules, No 
hydrogen bonding between host and guest was indicaled from a detailed analysis of the host-
guest interactions and it is thus concluded that the guest is excllJsively stabilized in the hosl 
cavity by hydrophobic interactions 
7 .5.2.3 Crystal Packing Arrangement 
Figure 60 is a stere<)v iew showing the crystal packing viewed along [100]. There are no 
hydrogen bonds between adjacent complex units, Water molecules are also not included in the 











Chapter 7 Results and discussion 
FigurQ 60 : Crystal pocking diagram "t~r~o~iew along the [1 00:, O. oclion 
The guest residues that protrude from the secondary side of the host fill spaces surrounded by 
symmetry-related complex units. Interestingly. when this complex is compared with the 
complexes TRIMEB-(Z)-Ajoene and TRIMES-(E}-Ajoene. a disordered arrangement, comprising 
both the R- and S-enantiomers of the guesl, was identified witf"Hn Ihe host cavity, a situation that 











Chapter 8 Biological Studies 
8.1.2 Growth of WHC01 cells 
All work on the cells was performed in a sterile tissue culture hood. Cancer cells used for this 
study were WHC01 oesophageal cancer cells established from surgical biopsies. The cells 
were cultured in DMEM containing 10% fetal calf serum and 1 % penicillin and streptomycin at 
37°C in a humidified atmosphere of 5% CO2. Cells were grown on 150 mm sterile tissue 
culture plates and split 1: 12 every four days. Briefly, the media was first removed and the cells 
were washed with PBS (10 ml). Trypsin (10 ml) was then added and the cells were incubated 
with trypsin at 37°C for 2 min. The detached cells were then transferred to a sterile 12 ml 
conical tube and centrifuged at 1000 x g for 3 min. The cell pellet was then re-suspended in 
DMEM (8 ml) and the cells split 1: 12. DMEM is Dulbecco's Modified Eagle Medium which is a 
solution of salts and other nutrients that are used to keep mammalian cells in culture alive. 
PBS is phosphate buffered saline. 
8.1.3 The MTT assay 
WHC01 cells were rinsed and detached from the bottom of the plate with trypsin and counted 
using haemocytometer. 3 x 103 cells were then planted in sterile CellStar 96 well plates in 90 
I-IL DMEM per well. After 24 hours, the cells had attached to the bottom of the plates and the 
compounds solubilized in DMEM + 1 % DMSO (10 1-11) were added to the wells and DMEM + 
1 % DMSO. (10 1-11) alone was added to the control (no drug) to give a final concentration of a -
200 I-IM compound and 0.1 % DMSO. After 48 hours incubation period, 10 I-IL of the MTT 
labeling reagent (final concentration 0.45 mg / ml) was added to each well and incubated for 4 
hours in a humidified atmosphere at 3rC. One hundred microlitres of the solubilization 
solution (10% SLS in 0.01 M HCI) was then added to each well and the plates were incubated 
overnight at 3rC. The spectrophotometric absorbance of the wells was then measured at 595 
nm using a microtiter plate reader. The absorbance of the blank (media alone) was subtracted 
from the readings and the data were plotted using the software package Graphpad Prism 4 
using the dose-response curve (variable slope) to fit the data. The half maximal inhibitory 
concentration (IC5o) is generated from the software. Independent experiments were performed 
between four and twelve times and the average is reported. The 95 % confidence interval is 
reported for the data as a measure of the error. The plots are displayed in Figure 63 and the 
IC50 values are reported in Table 15. 
8.2 Analysis and Results 
The chemical structures of the compounds used in the study are displayed in Figure 47. 
Unfortunately, the Z-isomers for the propyl/propyl and propyl/methyl analogues could not be 











Chapter 8 Biological Studies 
was not accessible from the radical cyclization route used in view of likely addition of the vinyl 
radical onto the allyl double bond during the radical addition step. However, enough data were 
generated overall in order to be able to draw some preliminary conclusions on structure-
activity relationships. The IC50 data generated on WHC01 cells are displayed in Table 15, 
while the representative plots of the raw data obtained are displayed in Figure 63. 
8.2.1 Structure-Activity analysis of ajoene 
From the data, it can be seen that both E- and Z-ajoene are equally potent at inhibiting cell 
growth of WHC01 cancer cells. This implies that for ajoene, the stereochemistry about the 
double bond is not important for inducing cancer cell death. This is in contrast to ajoene's anti-
thrombotic activity where the Z-isomer is reported to be 1.3 times more active than the E-
isomer at inhibiting platelet aggregation.27 In contrast to what was found for ajoene, for the 
propyl/allyl isomers, the Z-isomer was found to be 1.7 times more active than the E-isomer at 
inhibiting the cell growth of WHC01 cancer cells. It can be seen that substituting allyl for 
propyl on the sulfoxide end is tolerated without a change in anti-cancer activity for the Z-
isomer (21.6 vs 20.5 IJM for Z-propyl/allyl and Z-ajoene resp.), but causes a reduction in 
activity for the E-isomer series (35.8 IJM vs 20.5 IJM for E-propyl / allyl and E-ajoene resp.). 
Converting allyl/propyl to propyl/propyl does not affect the anti-cancer activity of the E-
isomers (35.8 IJM vs 33.8 IJM for E-propyl / allyl and E-propy / propyl respectively), but 
substitution of the propyl group at the disulfide end for a methyl group decreases the activity 
(33.8 IJM vs 47.4 IJM for E-propyl / propyl and E-propyl / methyl respectively). 
In summary, end-group changes appear to reduce the activity more for the E-isomer than the 
z-. However, the data suggest that the pharmacophore of ajoene resides in the sulfoxide -
vinyl disulphide core and not with the terminal groups. From a drug-discovery perspective, this 
is important as it opens up an avenue to generate more potent ajoene analogues by varying 
the physical characteristics of the groups at either end of the molecule but retaining the 
central active core. 
8.2.2 Inclusion of PMB into a cyclodextrin 
The most active analogue in the series, the p-methoxybenzyl analogue, was included into the 
cyclodextrin TRIMEB in an attempt to improve its bioavailability. The ajoene analogues are 
water insoluble and the inclusion methodology is used to solubilize the drug within the core of 
a soluble cyclodextrin. To our surprise, the inclusion complex was seven-fold less active at 
inhibiting WHC01 cancer cell growth than the non-included compound (IC5o = 51.6 vs 7.1 IJM 
for inclusion vs non-included PM B). This may likely be due to the fact that the PMB compound 
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to gain entry through the lipophilic membrane into the cell. From a bioavailability perspective, 
the inclusion complex may be important but in our in vitro assay system, this method of 
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Figure 62: Che mical structures of the ajoene analogues synth esize d for the study 
Table 15: IC50 values of the tested compounds on WHC01 cells 
Compound N IC50 /IJM 95%CI 
E-ajoene 6 20.9 20.7 - 21.1 
Z-ajoene 6 20.5 20.2 - 20.8 
Z-propyl / allyl 12 21.6 21.5-21.7 
E-propyl / allyl 10 35.8 35.5 - 36.0 
E-propyl / propyl 4 33.8 34.2 - 33.4 
E-propyl / methyl 5 47.4 47.1 - 47.7 
TRIMEB 4 none None 
para-methoxbenzyl 6 7.1 7.1-7.20 











Chapter 8 Biological Studies 
WHC01 cells treated with Z-allyl-propyl WHC01 cells treated with E-methyl-propyl 
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Figure 63: Plots of MTI data: absorbance obtained at 595 nm vs log of the drug concentration. Data analyzed 
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8.2.3 Dependence of the ICso on the lipophilicity of the compound 
The Log P values of the compounds as a measure of compound lipophilicity were calculated 
using a free online software package and the IC50 for the compounds in the E-series was 
plotted against the Log P. We did not plot similar data for the Z-series as some of the 
analogues in this series were missing as mentioned before. A good correlation between Log P 
and the IC50 was observed (Figure 64). This implies that the lipophilicity of the compound is 
important for anti-cancer activity on WHC01 cells. This may be related to the compound's 
ability to rapidly diffuse across membranes or may be related to a specific binding interaction 
between the compound and a specific protein at the target site. Since the target of ajoene in 
Chapter 8 Biological Studies 
Chapter 8: Biological studies 
8.1. Measurement of anti-cancer activity 
The synthesized ajoene analogues were tested for their ability to inhibit cell growth of WHC01 
cancer cells using the MTT assay.125,126 The WHC01 cell-line is an oesophageal cancer cell-
line of South African origin which was originally established from surgical biopsies of primary 
oesophageal squamous cell carcinomas. 127 In this assay, different concentrations of the 
ajoene analogue are added to WHC01 cancer cells that have been grown in a 96-well plate. 
The analogues are incubated with the cells for 48 hours and then MTT {3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetazolium bromide} in PBS is added to each well and incubated with the 
cells for 4 hr. Metabolically active (or living cells) contain an intact mitochondrial reductase 
which metabolizes the soluble yellow MTT reagent into a crystalline blue formazan precipitate 
(see Figure 61 below). Dead cells therefore cannot metabolize MTT. The crystalline MTT is 
then solubilized with detergent and the absorbance at 595 nm is measured for each well. The 
intensity of the blue colour (absorbance) gives a measure of cell viability from which a dose-
response curve can be generated. The IC50 is defined as the concentration which inhibits the 
growth of 50 % of the cell population. Therefore, the lower the IC5o, the more active the 
compound at inducing cell death. 
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more active than ajoene and the most potent analogue of the set with an IC50 below 10 !-1M. 
The enhanced activity of this analogue relative to the other analogues may be due to the fact 
that it still retains the central sulfoxide-vinyl disulfide pharmacophore but has increased 











Chapter 9 Conclusion 
Chapter 9: Conclusion 
In conclusion, a new synthetic sequence that is concise and cost-effective has been 
successfully developed for the synthesis of a small library of ajoene analogues. The 
synthesized analogues were biologically active at inhibiting the cancer cell-growth of WHC01 
oesophageal cancer cells. The p-methoxybenzyl analogue was threefold more active than 
ajoene and the most potent analogue of the set with an IC50 below 10 jJM. The observed 
increase in the biological activity of this analogue relative to ajoene was attributed to 
increased lipophilic character. Inclusion into the cyclodextrin TRIMEB resulted in reduced 
biological activity probably as a result of diminished delivery. 
Future studies will focus on further functional group changes in search of an advanced lead by 
retaining the pharmacophore and changing the end groups to other lipophilic moieties such as 
benzyl and substituted benzyl derivatives. Biological evaluation will be carried out on these 
derivatives. 
The mode of action of ajoene is believed to involve suppression of the anti-apoptotic protein 
bcl-2 but mechanistic detail is lacking on this process. A future avenue of research will be to 
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